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Abstract
A treatment room used for radiotherapy is generally heavily shielded and has to fulfil and
abide to strict rules and regulations in order to ensure the safety and health of hospital person-
nel and the general public that find themselves in the vicinity of the treatment room during
beam time. Secondary particles, especially neutrons and photons due to their neutral property
and induction rate, can carry and deposit energy a significant distance away from their initial
production site and potentially cause unintended damage and adverse effects in living tissue
and materials. Neutrons and photons are induced when energetic particles interact and col-
lide with matter, and in a radiotherapy treatment setting occurs not only in beam components
(degrader, collimator, etc.) that are introduced into the beam line, but also in the patient and
surrounding shielding. Fixed beam scanning therapy has the advantage of requiring a min-
imal number of beam components in the beam line and thus contain the main induction of
secondary particles to the patient and surrounding geometries. In this thesis a basic treatment
room with realistic dimensions modelled after a fixed beam scanning system facility, and a
water phantom functioning as a substitute patient, was implemented in the Monte Carlo sim-
ulation package FLUKA, and the geometry created using the flair - FLUKA Advanced Interface.
The beam placement, thickness and placement of main treatment walls, size and location of
water phantom and the treatment volume were all kept constant and consistent in all simula-
tions when applied. All results were further processed and normalised to a single fractional
delivery of 2Gy in the treatment volume.
The purpose of this master thesis has been to perform a comparative study of the induced
radiation environment inside a typical treatment room during irradiation of a water phantom
with proton, helium and carbon beams, and introduce various entrance structures and shield-
ing materials to the treatment room in order to compare and illuminate their effects and study
the differential fluence spectra of neutrons and photons entering and exiting these featured
structures. Water equivalent worker phantoms representing hospital personnel were placed
inside and outside the vicinity of the entrance structures and effective dose to each of them
were scored. A total of 24 simulations covering eight different treatment room layouts were
performed in FLUKA and the final results illuminated the many considerations and delibera-
tions that must be taken into account during the planning, building and shielding fitting of a
treatment room for use in particle therapy.
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Chapter 1
Introduction
Continuous developments in modern medicine and accelerator technology, and understand-
ing of how energetic particles in the atomic world interacts with matter, has created efficient
cancer treatments that offer improved tumour control and low probability of side effects com-
pared to radiation therapy with photons. Through the depth-dose characteristics of accelerated
protons, helium and Carbon ions makes it possible to deliver a dose to a target volume with
high precision. The first particle therapy facilities were built as early as 1957 and were mainly
used as research laboratories. In 2014 there were 48 particle therapy facilities in clinical oper-
ation around the world and in September 2013 the Norwegian Minister of health announced
that proton therapy facilities will be established in the respective administrative health regions
in Norway.
The planning and building of a particle therapy center is a costly and complicated affair
not least due to the radiation safety aspect that must be adhered too and follow the regulations
set in place to ensure the safety of the general public and hospital personnel in the vicinity.
While it is agreed upon that radiation effects increases with the absorbed dose, there is no gen-
eral consensus on set exposure limits. Instead, planned exposure situations follow a "as low
as reasonably applicable" principle coupled with a recommended dose limit that should not
exceed 20 mSv/year to an individual in an occupational setting or 1 mSv/year to a member
of the public. Medical particle therapy is considered a planned exposure situation and thus
requires careful planning and insight into a significant number of aspects, not only limited to
daily management, but also to shielding calculations and estimates that affect building lay-
outs, materials and detemination of areas to be kept under supervision.
With the aid of the Monte Carlo simulation tool FLUKA, this thesis aims to deliver insight
into the radiation environment induced inside a a typical fixed beam particle therapy treatment
room where protons, helium, and carbon ions are applied. Special geometries are introduced
in separate simulations where alternative entrances and shielding materials are featured. The
fluence and energy spectra of secondary particles, especially neutrons and photons due to their
penetrative properties, that exits and enters the featured structures are scored and plotted in
1
informative plots and tables. Parallel to these measurements, effective dose scoring in worker
phantoms located inside and in the immediate surroundings of the simulated geometry are
scored and used to calculate the annual dose.
The overall goals of this thesis has been:
• Create an actively modulated proton, helium and carbon beam in FLUKA that results in
a spread-out Bragg peak and suitable dose coverage of a clinical target volume located
inside a water phantom functioning as the patient.
• Investigate the secondary particles induced when a Monte Carlo simulated proton, he-
lium, and carbon treatment beam interacts with a homogeneous water phantom (hu-
man tissue approximation) and how the secondary particles propagates in the treatment
room.
• In the "FLUKA Advanced Interface", flair, use the geometry editor to design and build
a typical treatment room used in a fixed beam therapy setting and introduce various
structures and barriers that functions as entrances and shielding. Finally place human
sized water phantoms at locations inside the various entrances as well as outside pri-
mary shielding barriers.
• Compare proton, helium and carbon beam induced particle fluence entering and exiting
structural hallways and primary barriers.
• Score the effective dose in pre-arranged water phantoms functioning as hospital person-
nel and calculate the yearly workload they receive in these positions.
Chapter 2 introduces the basic physics most relevant for radiotherapy and are of concern in
radiation protection. Most prevalent are the interactions of charged particles, photons and
neutrons with matter. This chapter aims to build a foundation of physical concepts that are
involved when considering and discussing the origins of a radiation environment induced by
the interaction of energetic particles with matter.
Chapter 3 handles the biological effect of induced radiation on living tissue and introduces the
concepts, and radiological weighting factors, that are involved in evaluations of a radiation
environment and its potential effects on human tissue.
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Chapter 4 continues building on the theoretical foundation by introducing the technology and
methods involved in dose delivery, and concepts of LET and RBE that make up the rationale
behind the use of different particles in radiotherapy.
Chapter 5 forms the final piece in this thesis’s theoretical foundation and introduces the prin-
ciples of radiation protection and shielding in a radiotherapy setting.
Chapter 6 provides a general summary of the Monte Carlo method and FLUKA particle trans-
port code used in this thesis.
Chapter 7 describes the process of creating the three simulated proton, helium, and carbon
treatment beams in FLUKA. Outlines the various simulation setups and treatment room lay-
outs that were designed and simulated, together with their respective results and dose calcu-
lations.
Chapter 8 contains a final discussion and outlook.
All FLUKA Monte Carlo simulations in this thesis is produced by the author, unless specified
otherwise.
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Chapter 2
Radiation Physics
In this chapter the basic and most relevant concepts in radiation physics relating to radiation
therapy and radiation protection will be presented. In general, radiation is categorized as ei-
ther non-ionizing or ionizing depending on whether the radiation is carrying sufficient energy
to ionize atoms or not. Ionizing radiation, including γ-rays, X-rays, Charged Particles and Neu-
trons, have the power to excite and ionize atoms by transferring energy to valence electrons
and atomic nuclei on its path through matter[1]. These energy transfers occur via several dif-
ferent interaction processes and the energy imparted to individual atoms will cause a highly
localised concentration of absorbed energy. This energy absorption can consequently induce
biological effects in tissue and has therefore found an application in radiotherapy in medicine.
This application makes it imperative to understand the physics and models involved in the
interaction between radiation and matter.
2.1 Interactions of Charged Particles with Matter
Heavy charged particles, such as protons and heavy ions, that travel through matter will
mainly interact and lose energy via inelastic collisions with valence electrons and cause ion-
izations and excitations of atoms in their path. The incoming charged particles may also expe-
rience deflections from their incident direction due to elastic scattering on nuclei, complicating
the analysis of particle paths and energy deposition in matter. Bremsstrahlung, Cherenkov Radia-
tion and nuclear reactions may also occur, but these processes are rare compared to electromag-
netic interactions and inelastic collisions which are almost solely responsible for the energy
loss of heavy charged particles in matter [2].
2.1.1 Energy Loss by Ionization
A charged particle surrounded by its own Coulomb field, will interact with the Coulomb field
within every atom it passes and lose a small fraction of its incident energy through inelastic
collisions with the atom’s orbital electrons [1].
Instead of calculating this energy loss classically with Bohr’s formula in terms of the impact
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parameter, the more correct quantum mechanical Bethe formula, parametrized by the measur-
able momentum transfer, is used in calculations. [2]. The average energy loss of a heavy
charged particle per unit path length, dE/dx [MeV/cm], also called the stopping power, is given
by the Bethe formula and reads;
−dE
dx
= Kρ
Z
A
z2
β2
[
ln(
2mec2β2γ2Wmax
I2
)− 2β2 − δ− 2 C
Z
]
, (2.1.1)
where
K = 2piNAr2e mec
2 ≈ 0.307MeVmol−1cm2 .
Certain important effects and observations are of note in Bethe’s formula: i) To the first
order the energy loss is proportional to the inverse square of the incoming particle’s velocity,
1/β2. So as the incoming particle slows down in matter due to its energy loss, and experiences
the electric force from atomic electrons for a longer time, it will deposit more of its energy
until reaching a certain point where it will deposit all its energy and stop completely. This
is illustrated by a sharp dose enhancement referred to as a Bragg Peak when plotting depth-
dose curves for heavier charged particles (found in more detail in the Bragg Peak topic 2.1.5).
There is also a strong dependence on the square of the incident particle’s charge, z2, so for
heavier nuclei this dose enhancement effect is even more pronounced [3]. ii) By dividing the
stopping power 2.1.1 with the density of the absorber material, the mass stopping power, dE/ρdx
[MeVcm2/g] is obtained, and because the ratio Z/A is observed to have little variation from
material to material, from ∼ 0.5 for low Z to ∼ 0.5 for high Z (except for Hydrogen where
Z/A ≈ 1), the mass stopping power is almost independent from the type of absorber material.
Meaning that the incident charged particle will lose about the same amount of energy per
g/cm2 in any type of pure material [3]. For compound materials, 2.1.1 must be modified by
using Bragg’s additivity rule, which states that the stopping power of a molecule or material is
the sum of the stopping power of all the atoms it is composed of and thus defining effective
values for Z, A, I, etc.:
Ze f f = ΣaiZi ,
Ae f f = Σai Ai ,
ln(Ie f f ) = Σ
aiZi ln(Ii)
Ze f f
,
δe f f = Σ
aiZiδi
Ze f f
,
Ce f f = ΣaiCi ,
where ai is the number of atoms in compound i [2].
In figure 2.1, a representation of the stopping power 2.1.1 as a function of an incoming
charged particle’s kinetic energy is plotted, starting at zero and for increasing energy, three
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Table 2.1: Parameters involved in the Bethe Formula [2, p.24].
NA Avogadro’s number = 6.022× 1023mol−1
re Classical electron radius = 2.818× 10−15m
me Electron rest mass = 0.511MeV/c2
c Speed of light = 299792458m/s
z Charge of incident particle in units of e
ρ Density of absorber material
Z Atomic number of absorber
A Atomic weight of absorber in units of g/m
β v/c of the incident particle
γ Lorentz factor 1/
√
1− β2
Wmax Maximum energy transfer in a single collision
I Mean excitation potential (eV)
δ Density correction
C Shell correction
regions are of note. In the low energy region (1), β ≤ 0.05, particles tend to pick up electrons,
effectively lowering the charge and thus the stopping power. Due to these electron capture
effects the Bethe formula breaks down and there is no satisfactory theory to take its place in this
region. In the intermediate energy region (2), the stopping power decreases until the particle
reaches velocity, v ≈ 0.96c, when the particle is considered to be minimum ionizing. With
increasing energy in the relativistic region (3), there is a relativistic rise due to the logarithmic
dependence and correction terms in 2.1.1 [2].
It is also of note that for electrons and positrons, the Bethe formula must be modified in
order to take into account the added energy loss mechanism from scattering, as the low mass
of electrons and positrons give them a higher probability to scatter on atomic nuclei and radiate
electromagnetic radiation (bremsstrahlung) [2].
2.1.2 Range
Since a charged particle traversing through matter continuously lose energy from undergoing
a multitude of interactions, it will trace out a path until stopping completely due to its energy
loss. This path-length will approach an expectation value called range,R, and is a characteriza-
tion of the charged particle’s type, energy and specific medium it traverses [1].
Assuming the charged particle continuously lose energy at a linear rate along its path, the
range can be found by integrating over the reciprocal of the stopping power 2.1.1 [4],
R =
Rw
0
dx =
Ew
0
(
− dE
dx
)−1
dE . (2.1.2)
The stopping power is proportional to 1/β2, which varies with the energy, so it is expected
that the range is proportional to E2 as can be seen in the semi-empirical approximation of the
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Figure 2.1: Representation of the stopping power as a function of the kinetic energy of a heavy
particle [3, p.248].
range based on a simplified Bethe formula [5],
R ≈ pie
2
0meE
2
nAZAZ2e4M
, (2.1.3)
where e0 is the permittivity of free space and nAZA is the average electron density of the ma-
terial. It is important to note that the range calculated by 2.1.2 is only valid as long as inelastic
atomic collisions are the principal mean of energy loss. This is the case for heavy charged
particles in the therapeutic energy range and the results are accurate within a few percent [2].
Based on certain assumptions that the error in 2.1.3 are the same for different particles and
energies, it is possible to derive scaling laws for the ranges [5, 2]:
i) For different particles in the same medium,
R2(E2) = M2M1
z21
z22
R1
(
E2
M1
M2
)
. (2.1.4)
ii) For two absorber materials with different densities ρ0, ρ1 and atomic weight Ao, A1, where
the range is known in one, we can estimate the range of the charged particle in the other based
on the Bragg-Kleeman rule [6],
R1
R0
∼= ρ0
√
A1
ρ1
√
A0
. (2.1.5)
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iii) A rough approximation of the range in a compound can be found from
Rcomp = Acomp
Σ aiAiRi
, (2.1.6)
where Acomp is the molecular weight of the compound, ai is the number of atoms in the ith
compound element molecule, and Ai and Ri are the atomic weight and range of the ith con-
stituent element respectively [2].
When studying range curves it is observed that the range follows a simple power law equa-
tion,
R(E) = αEp , (2.1.7)
where E is the initial energy of the particle, α is a material-dependent constant and p is an
energy-dependent parameter that are obtained by fitting 2.1.7 to experimental range or stop-
ping power data [7, 8].
2.1.3 Multiple Coulomb Scattering
Another phenomenon of concern in analysis of particle paths are the scattering from atomic
nuclei due to the Coulomb force. Multiple small-angle scattering events, referred to as multiple
Coulomb scattering, causes a heavy charged particle to deviate from a straight line, resulting
in beam divergence illustrated in figure 2.2 [4].
The conical angular distribution of such a deflection is roughly Gaussian at small angles
and the solid angle θrmsspace where 98% of the beam is concentrated is given by [9]:
θ0 = θ
rms
plane =
1√
2
θrmsspace , (2.1.8)
θ0 =
13.6MeV
βcp
z
√
x
X0
[1+ 0.038 ln(
x
X0
)] , (2.1.9)
where z is the charge of the incoming particle, βc is the velocity, p is the momentum in MeV
and x/X0 is the thickness of the material in radiation lengths, which can be approximated by,
X0 =
716.4A
Z(Z + 1) ln( 287√
Z
)
. (2.1.10)
For 10−3 < x/X0 < 100, θ0 is accurate to 11% or better [10].
Generally, the lateral displacement and width of the beam due to multiple Coulomb scatter-
ing decreases with increasing charge and mass of incoming particle, but increases for materials
with high Z and for low energies as described by the βcp term in the denominator of 2.1.9, re-
sulting in a lateral widening of the beam as illustrated in figure 2.3 for some proton and carbon
energies [11].
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Figure 2.2: An exaggerated representation of the lateral displacement due to multiple Coulomb
scattering of a heavy charged particle after a thickness of material x [9].
Figure 2.3: Lateral width, of a typical treatment beam line with an initial FWHM of 5mm,
as a function of path length for proton and carbon ions in air and water. This illustrates the
increased lateral displacement of particles with lower energies and charges, and when pene-
trating materials with higher Z [11].
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2.1.4 Straggling
Fluctuations in the range will also occur because of the statistical nature of particle interactions
and energy loss in matter. Due to this random nature, not all mono-energetic particles entering
an absorber will travel the exact same path, resulting in statistical variations referred to as
range straggling, σrs and energy straggling, σrs. To the first approximation, straggling follows a
Gaussian distribution with a straggling parameter that depends on the massive-particle charge
and velocity, and the atomic number and ionization energy of the absorber [12].
The ratio of the range straggling and mean range is roughly proportional to 1/
√
M, causing
heavier ions to experience less straggling, narrowing the localisation of deposited dose [11].
For heavy charged particles the range straggling is only of a few percent and thus travel in an
approximately straight line while being narrowly distributed around the mean range [4].
2.1.5 Bragg Peak
As a charged particle loses velocity due to the energy loss caused by interactions with matter,
the cross section and interaction rate increases and causes a sudden maximum energy transfer
close to the particle’s range. This results in the phenomena know as a Bragg Peak and is used in
hadron therapy to concentrate the dose, and consequently the biological effect, to a given area.
After the Bragg peak has reached its maximum, the dose quickly falls to zero for protons, but
for particles heavier than protons a dose tail appears due to fragmentation [13], which is dis-
cussed in the fragmentation topic 2.1.6 below. For a mono energetic beam experiencing range
and energy straggling effects there is also a broadening of the Bragg peak to a few millimetres
as seen in figure 2.4. The width between the distal 80%, d80 and 20%, d20 dose level in the Bragg
peak depend on the quadratic sum of these two straggling effects [14],
d20 − d80 = 1.3
√
σ2esσ
2
rs . (2.1.11)
Generally, the straggling is roughly proportional to the inverse square root of the mass of
the particle, so for protons this widening is more pronounced than it is for heavier particles
[15], as observed in figure 2.4 below.
10
Figure 2.4: FLUKA Monte Carlo Simulations. Comparison of simulated Bragg peaks for a
proton and Carbon (12C) beam normalized to the same peak height. The broader width of the
Proton Bragg peak is due to stronger straggling effects while the tail at the end of the Carbon
Bragg peak is due to fragmentation.
2.1.6 Nuclear Fragmentation
Figure 2.5: Illustration of nuclear fragmentation described by the Abrasion-Ablation model
[11].
In fragmentation, incoming charged particles heavier than protons may lose one or more of
its nucleons via peripheral collisions with nuclei in matter as described by the abrasion-ablation
model shown in figure 2.5. In the first abrasion step, nucleons in the overlapping zone between
the projectile and target nuclei are abraded and form a reaction zone ("fireball"). The remain-
ing fireball, projectile and target fragments then de-excite in the ablation step by evaporating
light clusters and nucleons. This process leads to significant effects such as attenuation of the
primary beam flux and a build-up of lower Z fragments [11].
Neutrons and light clusters from the target fragment are isotropically emitted and have
much lower energies than the primary ions. Particles emitted from the projectile nuclei how-
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ever, are forward peaked with an angular FWHM that diminish with the increasing Z of the
fragments. Fragment energies are also close to the beam energy at the point of abrasion, this
causes the characteristic dose tail to appear behind the Bragg peak due to the larger penetrative
depth of lower-Z fragments. While the energy distribution of heavier fragments extends up
to the incident beam energy, neutrons and protons can extend up to twice the energy of the
incident projectile per nucleon, which is explained by the Fermi-momentum transfer from the
target nucleons [16].
2.1.7 Hadronic Cascade
When a high energy particle interacts with matter, a cascade (shower) of secondary particles
with lesser energy are produced, which can in turn produce new particles in the same manner
and continue the cascade. Hadronic cascade is the most important means of transporting ra-
diation through shielding barriers. There are six distinct and independent processes involved
in a hadronic cascade as illustrated in figure 2.6. The extra-nuclear cascade is the most impor-
tant due to the hadrons interacting directly with the nucleus and releasing forward directed
particles that propagate the shower further. Intra-nuclear cascade may also occur when the in-
coming particle interacts with individual nucleons inside the nucleus, this creates similar par-
ticles as the extra-nuclear, but at lower energies at wider angles. Above the pion production
threshold (135 MeV), pions may also contribute to the cascade by initiating an electromagnetic
cascade when decaying into two photons. Some of the charged pions and kaons will also re-
lease a muon when decaying and this will deposit its energy by ionization due to being a very
penetrating particle. The remaining struck nucleon de-excites by emitting mainly low energy
neutrons and protons (as described in the nuclear fragmentation section) that deposits energy
both locally (protons) and continuously over a distance (neutrons). The de-excited nucleus
may also be radioactive and emit α , β or γ radiation. For incident hadrons with therapeutic
energies, intra-nuclear cascade is the principal process and special consideration are paid to the
induced neutrons in intra-nuclear cascades as the induced charged particles do not contribute
significantly to the energy transport in matter since they are quickly stopped through their
energy loss via ionization. Neutrons are therefore the main propagators of energy in barriers
and requires special attention in shielding applications [17, 18].
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Figure 2.6: Illustration of the six levels of hadronic cascade [18].
2.2 Interactions of Photons with Matter
Photons are neutral, massless particles that carry electromagnetic energy and indirectly ionizes
atoms by transferring energy to charged particles through the principal interactions Photoelec-
tric Effect, Compton Scattering and Pair Production. Other interaction processes include elastic
Rayleigh Scattering that redirects the photon, but does not cause ionization, excitation nor en-
ergy transfers to charged particles, and Photo-nuclear interactions where photon energies above
a few MeV may produce neutrons. These interactions and their effects are not discussed in
great detail in this thesis, but their effects are observed in measurements of the total cross
section contributions seen in figure 2.7 [1, 5].
The total cross section of a photon interaction is the sum over all the contributing photon
interaction cross sections,
σtot = σpe + σcomp + σray + σpairn + σpaire + σph.n , (2.2.1)
where σpe is the photoelectric effect, σcomp and σray are Compton and Rayleigh scattering re-
spectively, σpairn and σpaire are the cross sections for pair production in the nucleus and in the
atomic electrons, and σph.n is the photo-nuclear cross section [19].
Depending on the incoming photon energy and the density and atomic number of the ab-
sorber, a photon may interact with an orbital electron or with the nucleus of an atom. The
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photon is then either absorbed and a portion of its energy transferred to an electron or used to
create an electron-positron pair, or the photon is scattered with or without an energy loss [3].
So contrary to charged particles that experience energy degrading and have a characteristic
range in matter, photons only experience a loss in intensity as they are either attenuated or
transmitted in matter. This loss of intensity is given by the exponential decay law,
I(x) = I0e−µx , (2.2.2)
where I is the intensity at depth x. I0 is the intensity without an attenuator and µ is the linear
attenuation coefficient, which denotes what fraction of the intensity is lost per unit length. The
linear attenuation coefficient is also related to the total cross section via
σtot =
µA
ρNA
, (2.2.3)
where A is the atomic mass, NA is Avogadros number and µ/ρ is the mass attenuation coeffi-
cient [5]. The linear attenuation coefficient is observed to increase with the atomic number Z
and density ρ of the absorber, and decrease with increasing photon energy, Eγ. Table 2.2 lists
the energy range and Z-dependence of some processes that contribute to the attenuation of a
photon beam. Primarily, attenuation is caused by the photoelectric effect, Compton scattering
and pair production, and these processes will be introduced in more detail in their respective
sections below [20].
Table 2.2: Table of processes contributing to the attenuation of a photon beam [5]
Process Target Energy range Z-dependence Comment
Photoelectric effect Bound electron 0− 0.5MeV Z4 − Z5 Absorbed photon
Rayleigh Scattering Bound electron < 1MeV Z2 − Z3 Coherent
Compton Scattering Quasi free electron ∼ 1MeV Z Incoherent
Nucleon > 100MeV Incoherent
Pair Production in nuclei field > 1.022MeV Z2
in electron field > 2.044MeV Z
Photonuclear effect Nuclei > 10MeV Absorbed photon and
particle emission
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Figure 2.7: The different processes contributions to the total cross section as a function of en-
ergy [21]. The photo electric effect dominates in the lowest energies, pair production starts at
∼1.022 MeV and is the dominating process for higher energies. Compton scattering reaches its
maximum around 1 MeV, but is present for a relatively wide range of intermediate energies.
2.2.1 Photoelectric Effect
The incident photon transfer all its energy to a bound orbital electron and if the energy of the
photon is higher than the binding energy of the electron, then the electron, referred to as a
photo electron, is ejected with the kinetic energy,
Ekin = Eγ − Ebinding . (2.2.4)
This process is illustrated in figure 2.8.
The cross section of photoelectric effect is roughly proportional to Z5/E3.5γ , and so it in-
creases rapidly with the Z of the absorber material, but decreases with increasing photon en-
ergy [14]. This is witnessed in figure 2.7 by the declining cross section for increasing photon
energies, but with the presence of characteristic absorption peaks as the photon energy reaches
the binding energy of electrons in the deeper shells (K,L,M shells illustrated in figure 2.8) caus-
ing the cross section to increase. Photoelectric effect occurs primarily with K-shell electrons
and when the vacancy is filled by an electron from the upper energy shell, a characteristic x-
ray is emitted [20]. It is of note that at energies where photoelectric effect is the main process,
the energy deposited by the photo electron is considered to be absorbed locally due to its short
range [5].
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Figure 2.8: Illustration of Photoelectric Effect. An incoming photon is absorbed by an orbital
electron which in turn is ejected and a outer laying electron fills the vacancy while emitting
characteristic radiation [22].
2.2.2 Compton Scattering
As illustrated in figure 2.9, an incoming photon with energy Eγ = hv transfers a fraction of
its energy to a loosely bound (or free) orbital electron via an inelastic collision and is deflected
from its incident direction while carrying the reduced energy
E
′
γ = hv
′
=
hv
1+ e(1− cos θ) , (2.2.5)
where e = hv/mec2 and θ is the scattering angle of the photon. The scattered photon, from
having lost only a portion of its energy, may undergo further photoelectric or Compton inter-
actions as it continues to travel through matter.
The ejected electron receives the energy
Ee = Eγ − E′γ = hv
e(1− cos θ)
1+ e(1− cos θ) , (2.2.6)
and may cause further excitations and ionizations in its continued path [20, 22]. The additional
scattering angle relations from applying energy and momentum conservations are [2]:
cos θ = 1− 2
(1+ e)2 tan2 φ+ 1
, (2.2.7)
cot φ = (1+ e) tan
θ
2
, (2.2.8)
From equation 2.2.6 and considering a photon making a direct hit on the electron and thus
scatter backwards at θ = 180◦, while the electron is ejected in the forward direction at φ = 0◦,
this maximum energy transfer is,
Ee,max = hv
2e
1+ 2e
, (2.2.9)
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also known as the Compton Edge [2]. From this maximum energy transfer equation 2.2.9 it is
evident that Compton scattering causes a larger energy deposition in matter when involving
higher photon energies than it does for lower energies[23]. It is also of note that Compton
scattering have little dependence on the Z of the material, but rather on the electron density
(electrons per cm3), this is because the electrons in Compton scattering are considered to es-
sentially be free.
Figure 2.9: Illustration of Compton Scattering [22, p.7].
2.2.3 Pair Production
Photons with energies above 1.022MeV, twice the electrons rest mass, can interact with the nu-
cleus directly and produce a electron-positron pair. The positron undergoes annihilation with
a free electron and creates two 511KeV annihilation photons as illustrated in figure 2.10. Pair
production varies almost linearly with Z2 of the absorber, and is the dominant interaction pro-
cess at energies > 10MeV where it accounts for almost all γ-ray absorptions in all Z absorbers
[? ].
Figure 2.10: Illustration of Pair Production. An incoming photon with an energy larger than
1.022MeV is transformed into an electron positron pair [22].
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2.3 Interactions of Neutrons with Matter
Neutrons, from not having an electric charge, are not subjected to any Coulomb interactions.
Instead, neutrons interact with the nucleus of an atom mainly through the strong force, which
makes them very penetrating particles due to the short range of this force. In an absorber,
neutrons interact by elastic scattering, inelastic scattering, neutron capture and nuclear reac-
tions, and similarly to photons they attenuate exponentially in matter and are categorized as
indirectly ionizing radiation [3].
Neutron interactions have a strong energy dependence, as inelastic scattering where the
neutron is absorbed by the nucleus and re-emitted with a lower energy and different direction,
can only occur when the neutron has sufficient energy, in the order of 1MeV and above, to
excite the nucleus. Below this threshold there is elastic scattering, where the recoiled nucleus
is given a fraction of the neutrons kinetic energy through momentum and energy conservation
laws. In nuclear reactions and neutron capture, the reaction cross sections are proportional
to 1/v, where v is the velocity of the neutron, making absorption more likely at low energies.
From these energy dependences, neutrons are classified according to their energies, high energy
neutrons are above≈ 100MeV, fast neutrons are between a few ten’s of MeV and a few hundred
keV. Between ≈ 100keV and 0.1eV neutrons are called epithermal, at energies ≈ 1/40eV they
are known as thermal neutrons, and at energies of meV − µeV they are cold or ultra-cold [2].
The probability for a neutron interaction is given by the sum of cross sections,
σtot = σelastic + σinelastic + σcapture + ... (2.3.1)
In practice it is necessary to rely on tables and databases of neutron cross sections for nuclei of
interest as there are no convenient way to calculate them [24, 25]. Neutron cross sections for
some light elements versus incident neutron energy are plotted in figure 2.11 by using such a
database.
If the target nucleus and captured neutron form a compound nucleus, and the energy con-
tribution from the neutron is close to an excited state of the compund nucleus, resonance peaks
where neutron reactions are enhanced occur. For lighter nuclei these resonances only occur in
the MeV region, while for heavier nuclei they can appear at neutron energies down in the eV
region [24].
2.3.1 Moderation
Moderation is the process of slowing down fast neutrons, when fast neutrons enter matter they
will scatter both elastically and inelastically on nuclei, losing energy until reaching a thermal
equilibrium with the surrounding atoms where it is either absorbed or undergoes an nuclear
reaction. Important factors in a moderator are the probability of scattering and the change
in kinetic energy of the neutron after an interaction. The maximum energy an neutron with
kinetic energy En can transfer to a nucleus with atomic weight A in a single head-on elastic
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Figure 2.11: Using the JANIS software [26] and database ENDF/B-VII.1 [25], the total (full
lines) and absorption (dotted lines) cross sections for some light elements versus incident neu-
tron energy were plotted.
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collision is
Emax =
4AEn
(1+ A)2
, (2.3.2)
this implies that lighter nuclei absorb more recoil energy and are thus more efficient at slow-
ing down neutrons than heavier nuclei [4]. In general, after n elastic collisions, the neutron’s
energy is expected to change to
En = E0[
A2 + 1
(A + 1)2
]n . (2.3.3)
By looking at the logarithmic change in energy, the number of collisions needed to reduce the
initial energy, E0, of a neutron down to a certain level En can be calculated [24],
n =
log( EnE0 )
log[ A2+1
(A+1)2 ]
. (2.3.4)
Some examples illustrating equation 2.3.4 are collected in table 2.3.
Element Atomic weight, A Number of Collisions, n
Hydrogen 1 27
Deuterium 2 31
Helium 4 48
Beryllium 9 92
Carbon 12 119
Table 2.3: Average number of collisions, n, needed to reduce a neutron’s energy from 2MeV to
0.025eV by elastic scattering.
2.3.2 Neutron Reactions
Some neutron reactions of interest in neutron dose deposition and radiation protection [4]:
1
0n+
1
1H→ 21H+ 00γ (2.3.5)
Absorption of thermal neutrons by hydrogen is followed by the emission of a gamma photon
with energy Q = 2.22MeV representing the binding energy of the deuteron (calculated by the
Q-value, which expresses the total energy released in a reaction by comparing the total masses
on both sides of the arrow [5]).
1
0n+
10
5 B→ 73Li+ 42α (2.3.6)
Boron has a large cross section concerning neutron absorption and is therefore used as a neu-
tron shielding material. Depending on what state 7Li is left in, the recoiled 7Li nucleus and
alpha particle will share Q = 2.31MeV in 96% of the reactions and Q = 2.79 in the other 4%.
If the 7Li is left in an excited state, as it does for 96% of the reactions, it will emit a 0.48MeV
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gamma ray.
1
0n+
14
7 N→ 146 C+ 01p (2.3.7)
Nitrogen is abundant in tissue and together with hydrogen are the only two capture interac-
tions that delivers a significant thermal neutron dose to tissue. The Q-value is 0.626MeV and
the resulting proton and 14C nucleus are deposited locally due to their short range.
1
0n+
113
48 Cd→ 11448 Cd+ 00γ (2.3.8)
Cadmium is used as a neutron shield and has a large, 21000 − barn, capture cross section
concerning thermal neutrons up to ≈ 0.2eV and absorbs essentially all neutrons below the
cadmium cut-off ≈ 0.4eV. The emitted gamma from this reaction has an energy of 0.56MeV
[27].
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Chapter 3
Radiation Biology
From a human health perspective the most significant aspect of radiation interactions with
matter is the deposition of energy in biological tissue and the development of health effects
caused by ionization events inside cells. Damage to tissue can be caused by direct breaking of
biological molecules (DNA), or indirectly through the production of free radicals.
With the inclusion of radiation biology, dosimetry aims to quantify the relationship between
deposited energy, referred to as dose, and biological effect. To this extent, certain dosimetric
quantities are defined by the ICRP and ICRU, these quantities have been modified several times
and are still evolving as there is not enough systematic data available to fully describe dose-
response relationships, but it is generally agreed upon that the severity of induced damage
increases with dose. Radiation therapy takes advantage of this by aiming to deposit a high
enough dose to a tumour volume in order to incapacitate cancer cells.
3.1 Dosimetry
Dosimetry relates specific measurements in a radiation field to physical, chemical or biological
changes in a target. These changes are quantified as a function of the amount of radiation
received and are used to assess radiation exposure in humans and to describe dose-response
relationships. Dosimetry is based on measurements of ionization and energy absorption in
matter, usually through the measurement of absorbed dose, and is essential in the surveillance of
a radiation environment and to determine dosimetric quantities like equivalent dose and effective
dose that are used to quantify changes in different biological tissue caused by different types
of radiation. These quantities are in turn applied in radiation protection to specify dose limits
that ensure acceptable safety in radiation environments [4, 28].
3.1.1 Absorbed Dose
The primary quantity used in dosimetry is the absorbed dose, often referred to as dose, D,
which is measured in Gray [Gy], where 1Gy = 1J/kg and describes the amount of energy dE
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deposited per unit mass dm for all types of ionizing radiation in any irradiated target [4],
D =
dE
dm
. (3.1.1)
This definition is suitable for use in micro dosimetry for describing localised doses in an in-
finitesimal mass element. Measurements of the absorbed dose however, do not provide suffi-
cient information about the type and energy of the radiation, nor about the tissue where the
energy is absorbed, the biological effects of the absorbed dose are therefore unpredictable. To
better predict these effects, two dose terms "equivalent dose" and "effective dose" are defined
by multiplying the absorbed dose with dimensionless weighting factors wR and wT [29].
Instead of the point function D, radiation protection usually make use of the average ab-
sorbed dose, DT, in a tissue or organ with mass, mT [5],
DT =
E
mT
. (3.1.2)
It is noted that this average dose approach assumes an uniform dose distribution, while in
practice, radiation effects are dependent on the distribution and may therefore make dose-
response relationships difficult to evaluate.
3.1.2 Equivalent Dose
Equivalent dose HT describes the biological effectiveness that certain types of radiation and
their energies, denoted R, have on a specified tissue or organ T, and is the sum over all types
of radiations involved.
HT =∑
R
wRDT,R , (3.1.3)
where wR is the radiation weighting factor that converts the average absorbed dose DT,R to equiv-
alent dose. The values of wR are defined to reflect the relative biological effectiveness (RBE) of
different types of radiations and energies.
wR ∼= 1D
w ∞
0
Q(L∞)D(L∞)dL∞ , (3.1.4)
where L∞ is the unrestricted linear energy transfer of the radiation in water , Q is the quality factor
as a function of L∞, and D(L∞)dL∞ is the absorbed dose between L∞ and L∞ + dL∞ [30]. Table
3.1 lists the 1990 recommended Q-factors and table 3.2 lists the current radiation weighting
factors from the 2007 ICRP recommendations for different types of radiations. Equivalent
dose has the same basic units as absorbed dose, but to emphasize the change from a physical
quantity to a biological response, it is referred to as Sievert [Sv] [29].
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3.1.3 Effective Dose
All dose limits in radiation protection are given in terms of effective dose and reflects the
biological effect of the average absorbed dose by considering the sensitivity that different tissue
types have to radiation. By introducing the tissue weighting factor, wT, which is normalized to
unity of the full body, defines the effective dose HE as [29],
HE =∑
T
wT HT =∑
T
∑
R
wTwRDT,R . (3.1.5)
Like equivalent dose, effective dose is measured in Sievert. The latest tissue weighting factors
recommended by the ICRP, listed in table 3.3, are based on stochastic effects like induced cancer
and heritable diseases rather than on mortality. It is also noted that the wT values are for use
in radiological protection and based on a reference population, so they "should not be used to
obtain estimates of potential health effects for a given individual" [29] [4].
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Table 3.1: Quality Factor Q as a function of L∞ in water [30].
L∞[keV/µm] Q
< 10 1
10− 100 0.32L∞ − 2.2
> 100 300/
√
L∞
Table 3.2: Radiation weighting factors recommended by the ICRP in 2007 [28].
Radiation type Radiation weighting
factor (wR) - 2007
recommendations
Photons 1
Electrons and muons 1
Neutrons, energy < 1MeV 2.5+ 18.2e−[ln(E)]2/6
1− 50MeV 5.0+ 17.0e−[ln(2E)]2/6
> 50MeV 2.5+ 3.25e−[ln(0.04E)]2/6
Protons and charged pions 2
Alpha particles, heavy nuclei 20
fission fragments
Table 3.3: Tissue weighting factors for different tissues as recommended by the ICRP in 2007
[28]
Tissue/Organ Tissue weighting
factor(wT) - 2007
recommendations
Gonads 0.08
Bone marrow (red) 0.12
Colon 0.12
Lung 0.12
Stomach 0.12
Breast 0.12
Bladder 0.04
Esophagus 0.04
Liver 0.04
Thyroid 0.04
Skin 0.01
Bone surface 0.01
Salivary glands 0.01
Brain 0.01
Remaining tissues 0.12
and organs
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3.2 Biological Effects of Radiation
Ionising radiation damages living cells by breaking DNA strands and by producing free rad-
icals that attack chemical bonds inside cells. Induced health effects depend on the type of
incident radiation and rate of energy deposition along the ionizing particle’s path, these quan-
tities are summarized in the term linear energy transfer (LET), where higher LET particles will
cause more biological damage than lower LET particles.
A damaged cell will usually repair itself with no visible effect, but if the damage is severe
enough, a cell will either: i) die, ii) have its natural function impaired (leading to cancer) or iii)
experience a permanent genetic alteration [2].
3.2.1 LET - Linear Energy Transfer
LET has units keV/µm and is defined as the amount of energy deposited per unit radiation
track length in matter. This is closely related to the stopping power 2.1.1, but does not include
energy that escapes the defined area in the form of photons or energetic electrons, making
LET≤ | − dE/dx|. In order to exclude the energy absorbed outside the area of interest, an
alternate definition of LET that disregards all secondary electrons with kinetic energies above
a limit, ∆, is defined [5],
L∆ = (−dEdx )∆ . (3.2.1)
L∞ is then read as the unrestricted linear energy transfer where LET is calculated with all
energies, making it equal to the stopping power. Only differentiating itself from the stopping
power due to bremsstrahlung photons carrying some energy away [5].
LET basically indicates the quality of different types of radiation. Particles with high LET,
including neutrons and heavy charged particles, will ionize and excite more molecules in their
paths and thus causes greater biological damage per absorbed dose in tissue than low LET
particles like photons. It is noted that LET varies as the particle slows down and deposits
more of its energy in matter [31].
3.2.2 RBE - Relative Biological Effect
Biological damage caused by radiation is strongly correlated with the radiation type and its
properties. This can be contrasted as a ratio between the dose, D needed to produce a specific
biological effect and the X-ray dose, DX that is needed to produce the same effect under the
same conditions.
RBE =
DX
D
. (3.2.2)
RBE is not a constant however, and depends on various properties like LET, dose rate and
dose fractionation, as well as the measured biological effect. Generally, RBE increases with LET
up to a point, as seen in figure 3.1 which illustrates RBE as a function of LET when concerning
cell death. Starting at low LET and as the density of ionizations and excitations increases with
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higher LET, so does the biological effect until it reaches an optimum around 100keV/µm. Any
further increase in LET result in more energy deposition than what is needed to kill a cell
(overkill) [4].
In radiation protection, RBE only appears in the derived quantities, Q(L∞) and radiation
weighting factor, wR [32].
Figure 3.1: Illustrating the relative biological effect’s dependence on linear energy transfer (as
cited in [22]). SF is and abbreviation of survival fraction
3.3 Health Consequences from Irradiation
Molecular changes in biological tissue can manifest itself as radiation damage and cause both
short-term and long-term health effects. High doses cause acute damage to tissue and organs
due to cell killing and result in observable short term deterministic effects. At low doses tissue
reactions are not observed, but future stochastic effects from damaged genetic material may
occur in the long term and are assumed to increase with dose.
3.3.1 Short term effects
At high doses above a threshold dose, deterministic effects and acute tissue reactions are ob-
servable. Among tissue reactions, loss of the reproductive capacity of cells and cell death play
a central role in the development of tissue damage. Some of the more radio-sensitive tissues
and organs consists therefore of cell systems that divide rapidly. Late tissue reactions may also
appear if there is damage to blood vessels or tissues that are important for organ functions,
these reactions can appear months or years after radiation. All deterministic effects exhibit a
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threshold characteristic, an effect has therefore a certain probability of occurrence above this.
As radiation weighting factors are derived from stochastic effects at low doses, the equiva-
lent dose and effective dose should not be used in quantifying radiation doses or determining
treatment in situations where tissue reactions are caused by high doses. Absorbed dose or dose
equivalent should instead be used in such instances [28].
3.3.2 Long term effects
In the low dose range, stochastic effects such as induced cancer or heritable diseases may ap-
pear. As concluded by the UNSCEAR (cited in ICRP Report 103 [28]), the general assumption
concerning the risk of stochastic effects is that it increases linearly, with no threshold, in the
low dose range and that it does not depend on the dose rate, but on the total accumulated
dose. There is however insufficient data available in the range below 0.5− 1Gy to determine
any dose-response relationships or basis for dose limits. The risk of stochastic effects depends
only on the effective dose as there are notable differences between different types of tissues and
organs when it comes to the sensitivity of radiation inducing stochastic effects, as are reflected
in the wT values in table 3.3 [28].
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Chapter 4
Particle Therapy
Using protons and heavy charged particles in medical treatment, given their characteristic
depth dose distribution enabling a relatively precise dose delivery to a target volume while si-
multaneously sparing and reducing deposited dose to surrounding healthy tissue and organs,
was first proposed by the American physicist Robert R. Wilson in 1946 [33]. Since then, over
137 000 patients have been treated with particle therapy and in 2014 there were 48 particle ther-
apy facilities in clinical operation around the world and treated approximately 15 000 patients,
of which 86% were treated with protons and 14% with carbon ions and other particles [34].
4.1 Radiation Treatment with Charged Particles
The basic goal of radiation therapy is to kill tumour cells while simultaneously minimizing
damage to healthy tissue, ideally this would be achieved by delivering a prescribed dose to
a tumour while maintaining zero dose to normal tissue. Unfortunately, due to the intrinsic
properties of the depth dose distribution will an increased tumour dose also increase nor-
mal tissue dose. This is reflected in the therapeutic ratio that assesses the radiation treatment
quality as a ratio between tumour control probability (TCP) and normal tissue complication prob-
ability (NTCP). The therapeutic ratio, also referred to as the therapeutic window, is illustrated
in figure 4.1. The choice of treatment plan and dose delivery technique aims to widen this
window by achieving good TCP while simultaneously keeping the NTCP low [35]. Hadron
therapy accomplishes this with its depth dose distribution characterized by a small entrance
dose and distinct Bragg Peak followed by a sharp distal fall-off near the particles range. The
small lateral beam spread and enhanced biological effectiveness, especially of heavier charged
particles, further improves the therapeutic ratio. There are however several considerations and
factors involved when choosing what type of particle to use in hadron therapy [11].
Ions heavier than protons show an improved dose conformity due to their larger mass and
close to negligible straggling effects and consequently offer better sparing of normal tissue
close to the target. Heavy ions also exhibit an increased LET in the Bragg peak and this allows
for a high LET region to be conformed to the tumour, increasing the RBE characteristic that
allow for an improved TCP. As seen in figure 4.2, Carbon has an excellent RBE ratio (Bragg
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peak vs. entrance region) compared to protons and helium. Ions heavier than neon however
show a higher RBE in the entrance region than in the Bragg Peak, consequently increasing the
NTCP.
Heavy ions also have the disadvantage of fragmenting into light clusters and neutrons that
give rise to a fragmentation tail beyond the Bragg peak which increases the NTCP. There is also
the aspect of accelerating particles to energies that are required to treat deep-seated tumours: a
proton beam of≈ 146 MeV can penetrate about 15 cm in water, while a carbon ion requires over
3200 MeV (or about 270 MeV/u) to achieve the same depth. In order to accelerate particles to
such energies, a synchrotron is the most suited and this is a much more complicated and cost
intensive as opposed to a cyclotron which is widely used in proton particle therapy [36].
Figure 4.1: Two sigmoid shaped dose-response curves illustrating the TCP and NTCP and the
gap between showing the therapeutic window [37]
Figure 4.2: The RBE of different ions in different positions of a SOBP with modulation depth
8-10cm. Initial beam energy was 160, 225, 400, 557 and 570 MeV/u for protons, helium, carbon,
neon and argon ions respectively [36].
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4.2 Spread Out Bragg Peak - Energy Modulation
A mono energetic beam from an accelerator will only form a pristine Bragg peak in matter,
so in order to cover a target volume longitudinally, multiple Bragg Peaks of different ranges
and intensities are superimposed to form a Spread Out Bragg Peak (SOBP). Each Bragg peak is
further weighted by delivering a relative number of ions for each peak to achieve a flat dose
plateau [15]. This principle is illustrated in figure 4.3. To create multiple Bragg peaks and
shape the beam to a target volume in the clinic, two different methods are applicable, passive
beam shaping and active beam shaping[36].
(a) Longitudinal depth dose plot of 21 unweighed proton beams
with energies from 145 MeV to 172 MeV.
(b) The longitudinal depth dose plots of the 21 proton beams are
weighted and added together to form a SOBP with a flat dose
plateau covering the 15-20 cm range.
Figure 4.3: FLUKA Monte Carlo simulations. Illustration of the principle behind the formation
of a SOBP. Beams of several consecutive energies are added together and weighted to obtain a
flat dose plateau that covers a desired depth.
Passive beam shaping modulates the mono energetic beam from the accelerator by intro-
ducing a degrader (either a range modulator wheel with varying thickness or a ridge filter)
into the beam line. Then, in order to move the resulting SOBP to a certain depth, an additional
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range shifter consisting of homogeneous plastic plates of various thicknesses are introduced
into the beam line. The last step in passive beam shaping is to spread the beam laterally and
homogeneously over the target volume either by scattering or by a magnetic wobbling system.
Patient specific collimators and compensators are also used to shape the field to fit the struc-
ture (tumour) in the treatment volume [36]. This technique has three major disadvantages: 1.)
The depth dose profile can only be tailored to the distal end of the target. 2.) Presence of mate-
rial in the beam line lead to nuclear fragments that increase the NTCP in the entrance region.
3.) Large number of patient-specific beam modifiers must be manufactured.
Active beam shaping takes advantage of the particles electric charge to produce a pencil
beam that is deflected laterally by two magnetic dipoles, allowing for scanning of the beam over
a treatment volume. By using a modulator wheel, or a synchrotron that allows for adjustments
of the output energy pulse by pulse, the target volume can be covered in the longitudinal
direction while simultaneously scanning all three dimensions and fitting the dose distribution
to both the proximal and distal end of the target. This is mostly done without introducing
extraneous material into the beam line such as range shifters and compensators. This reduces
the production of nuclear fragments and thus decreases the NTCP [36]. Figure 4.4 illustrates
the principle and difference between an active and passive beam delivery system.
4.3 Fractionation
A typical radiation treatment is split into fractions depending on the diagnosis and treatment
type, for instance can a prescribed dose of 50 Gy commonly be fractionated into a standard
scheme of 2 Gy/fraction to be delivered in 5 days/week. This is done in order for healthy tissue
to repair itself and decrease the NTCP. Heavier ions such as carbon with their higher RBE can
invoke a better TCP and thus deliver a prescribed dose in fewer fractions (hypofractionation)
which reduces treatment time and cost while still maintaining TCP and NTCP without an
increase in side effects. Such alternative fractionation schedules are undergoing continuous
investigations, clinical trials and studies [15].
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Figure 4.4: (a) Illustrates passive beam shaping with a wobbling magnet, ridge filter(RGF),
range shift filter(RSF) and the inclusion of a collimator and compensator. (b) Illustrates the
active beam shaping method by scanning a pencil beam in both vertical and horizontal direc-
tion with scanning magnets. A synchrotron can also adapt the scanned area to certain depth
without introducing a range shift filter into the beam line [? ].
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Chapter 5
Radiation Protection
Radiation occurs naturally in nature and has a constant presence in peoples everyday life
through what is dubbed natural background radiation. This consists of external exposures from
cosmic radiation, and terrestrial radiation caused by the decay of natural radionuclide in the
ground, as well as internal exposures caused by the inhalation and ingestion of radionuclide
found naturally in air, water and food. Worldwide, the average dose to the human body from
naturally occurring radiation accounts to about 2.4 mSv per year [38].
Any additional dose contributions come from artificial radiation sources such as medicine
(medical imaging and radiotherapy), occupational hazards in the work environment, or caused
by accidental radiation exposure. There is no general consensus on exposure limits, but
planned radiation exposures follow the ALARP ("As Low As Reasonably Practicable") princi-
ple that attempts to declare a common practice centred around risk management that balances
risk and societal benefits. Averaged over the world, artificial radiation sources contribute with
an additional 0.61 mSv to the annual dose, with over 95% of this coming from medicine. How-
ever, with the increasing availability of modern medical imaging and radiotherapy, the annual
average dose contribution can reach the same level as the natural dose, as seen in the United
States where the average dose contribution from medicine is about 3.0 mSv [39].
With an emphasis on radiotherapy in medicine, this chapter will go deeper into the ratio-
nale behind radiation protection and the physical aspects of limiting exposure to the human
body through shielding applications.
5.0.1 Radiation Protection Recommendations and Guidelines
Several international and national agencies have been established with the intent of supervis-
ing, consulting and researching radiation effects and radiation protection in order to adopt rou-
tines, recommendations and technology that improves the security and safety of workers and
the general public at large. Some of these agencies includes the IAEA who create safety stan-
dards that incorporates information on health effects of radiation provided by the UNSCEAR
and also apply recommendations concerning radiation protection and radiation levels made
by the ICRP, whom in turn also takes the scientific information provided by the UNSCEAR
into their recommendations [35]. Many countries have their own competent authority on ra-
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diation protection and nuclear safety that supervise and manage the use of radiation sources
in medicine and research on a national level, in Norway this authority is "Statens Strålevern"
(NRPA) [? ].
In 2007 the ICRP issued a revision of their 1991 recommendations by taking new biological
and physical information into account while simultaneously improving and streamlining the
presentation of their recommendations. This revision culminated in Publication 103 [? ] which
updated radiation and tissue weighting factors, maintained individual dose limits and rein-
forced the principle of optimisation of radiation protection. These recommendations provide
a consistent basis for national and regional regulation standards and will be discussed further
in this section.
The ICRP base their recommendations on the assumption that doses below 100 mSv follow
the Linear-Non-Threshold (LNT) dose-response model in accord with that given by the UN-
SCEAR [28, 40]. Based on the implication made by the LNT model, that there is always a finite
risk involved in radiation, ICRP conceived three fundamental principles of any radiological
protection system [28]:
• Justification: "Any decision that alters the radiation exposure situation do more good than
harm."
• Optimisation of protection: "The likelihood of incurring exposures, the number of people
exposed, and the magnitude of their individual doses should all be kept as low as reason-
ably achievable, taking into account economic and societal factors."
• Application of dose limits: "The total dose to any individual from regulated sources in
planned exposure situations other than medical exposure of patients should not exceed the
appropriate limits recommended by the Commission."
While the recommendations in ICRP Report 103 are applied to all sources and exposed
individuals, they are differentiated by three types of exposure situations that take different
circumstances into account: i) Planned exposure situations where radiation sources are deliber-
ately introduced and operated. ii) Emergency exposure situations that may occur as a result of an
incident in a planned or unexpected situation. iii) Existing exposure situations where exposure
already exist and must be regarded. Another three exposure categories are further addressed
in order to distinguish between different exposure types in a given situation: 1) Occupational
exposure, radiation exposure to workers as a result of situation that is under the responsibility
of an operating management. 2) Medical exposure of patients that occur in diagnostic, interven-
tional and therapeutic procedures. 3) Public exposure that considers all exposures to the public
other than occupational and medical exposures.
Together with the principle of protection optimisation, three concepts of dose restrictions;
dose limit, dose constraint and reference level are defined and applied in their respective situations
in order to reduce the dose to a "as low as reasonable level". Table 5.1 lists the dose restrictions
applied in relation to the exposure situation and category, and figure 5.1 illustrates the contrast
between the different dose restrictions for occupational and public exposure. This thesis will
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Figure 5.1: Illustration of the contrast between dose limits, dose constraints and reference levels
for workers and the general public [28]
not go into detail of the framework around dose constraints and reference levels, but the reader
is referred to page 97 in the ICRP Report 103 [28].
Table 5.1: The ICRP’s dose restrictions shown in relations to the exposure situation [28, p.94].
Type of Situation Occupational exposure Public exposure Medical exposure
Planned exposure Dose limit Dose limit Diagnostic reference
Dose constraint Dose constraint level (Dose constraint)
Emergency exposure Reference level Reference level N.A.
Existing exposure N.A. Reference level N.A.
Dose Limits
The updated weighting factors recommended by the ICRP as seen in table 3.2 and 3.3 in chap-
ter 3 are used to specify the dose limits that ensure that health effects are kept below unaccept-
able levels. Re-evaluation of available data based on a broad range of RBE values updated the
previous 1991 recommendations for neutrons (from 5-20 to a function of neutron energy) and
protons (from 5 to 2), but maintained the wR values for photons and heavy ions. In a planned
occupational exposure situation it is recommended that the limit, expressed as effective dose,
should be 20 mSv per year averaged over defined 5 year periods (100 mSv in 5 years), and
with an additional condition that the effective dose should not exceed 50 mSv in any single
year. Table 5.2 lists the recommended dose limits for workers and the public in a planned
exposure situation.
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Table 5.2: ICRP’s recommended dose limits in a planned occupational and public exposure
situation [28].
Type of limit Occupational Public
Effective dose 20 mSv per year, averaged 1 mSv in a year
over periods of 5 years
Annual equivalent dose in:
Lens of the eye 150 mSv 15 mSv
Skin 500 mSv 50mSv
Hand and feet 500mSv -
5.0.2 Radiation Environment in Radiotherapy
All radiation in a radiotherapy treatment room, except for the primary beam, is comprised of
secondary radiation produced at locations where beam loss and scattering occurs, this takes
place during beam propagation in matter (patient and shielding) and in beam line devices. Sec-
ondary radiation particles that arise due to hadronic cascades, as described in chapter 2, section
2.1.7, are mainly comprised of neutrons, photons, protons, and fragmentation fragments with
energies up to the incident primary beam energy. The distribution of secondary neutrons for
protons, helium and carbon ion beams are very different however as fragmentation only oc-
curs for particles heavier than protons. The resulting projectile fragment from fragmentation
will emit high energy and forward peaked neutrons that are added to the isotropic neutron dis-
tribution from target fragments, as opposed to protons where there are no projectile fragments
present [? ]. Photon radiation produced by inelastic neutron scattering and neutron absorption
in matter also plays a role in the radiation environment, especially in thick shielding where the
higher density of neutron reactions emit photons, and for neutrons below 25 MeV where the
relative dose contribution from photons is higher. A radiation field of a specific type is fully
described by the fluence, energy, and spatial distribution of the particles.
Radiation Field Properties
The spatial distribution of radiation in a therapeutic setting is divided into two regions based
on the dose level and radiation quality. i) In-field volume is the directly irradiated volume
where primary particles dominates the dose delivery. ii) Out-of-field volume that surround the
in-field volume where secondary particles are the main contributors to dose delivery. In the
out-of-field volume for a fixed beam treatment room, the neutron dose rate from heavier ions is
higher in the forward direction than it is for protons, even though protons have a much higher
intensity (more protons are required to deliver a prescribed dose than what is required for
heavy ions), this is due to the mentioned fragmentation. At large angles however the isotrop-
ically emitted neutron dose from protons is higher than that from heavier ions. [? ]. Ideally
the energy and angular distribution of all particles throughout the entire room and shielding
would be known,
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Fluence describes the number of particles, dN, that passes through a cross-sectional area,
dA, normal to the beam direction and has the unit m−2:
φ =
dN
dA
. (5.0.1)
In radiation transport calculations, fluence can also be expressed as the density of particle
trajectories in a volume,
φ =
dl
dV
. (5.0.2)
Where dl is the sum of particle trajectories in the volume dV [17].
Neutron yield (number of neutrons emitted per incident primary particle) and energy of the
neutrons, generally increases with the energy and Z of the primary particle as illustrated in
figure 5.2 showing the neutron yield in tissue (ICRU tissue phantom composed of: 76.2% O,
10.1% H, 11.1% C and 2.6% N) in the forward (0◦ − 10◦ degrees) direction.
Figure 5.2: Total secondary neutron yield produced in the ICRU tissue phantom for various
ions with energies so that the range in water was 26.2 cm; protons (200MeV), helium (202
MeV/n), lithium (234 MeV/n), boron(329 MeV/n), carbon (400 MeV/n), nitrogen (430 MeV/n
and oxygen (468 MeV/n)) [17]
5.0.3 Radiation Protection in Radiotherapy
The IAEA has in its safety standards concerning radiation protection classified different radio-
logical areas that are of concern in a radiation environment [41]. Figure 5.3 illustrates these ra-
diological areas when applied to a particle therapy facility (in Germany, Italy and Switzerland
[17]). Areas where the beam is active are inaccessible (dark blue), controlled areas where specific
protection and safety measures are applied in order to control exposure and radiation contam-
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ination (light blue), supervised areas where occupational exposure is supervised, but without
any specific protective measures necessary (yellow), and public area that is unrestricted and
open for the general public (green).
Shielding Barriers in a Fixed Beam Treatment Room
A particle therapy treatment room is composed of barriers that intercept radiation and aim to
limit exposure leakage into supervised and public areas. Shielding walls, ceiling and floor are
all an integral part of a treatment room and are divided into primary and secondary barriers.
The primary barrier is the wall, or any other structure that intercepts the secondary radiation
emitted at 0◦ from the interaction between the primary beam and target. Any other barrier
that is not the primary barrier is considered to be a secondary barrier. Shielding walls in the for-
ward direction (primary barrier) are thicker than the ones in the lateral and backward facing
direction (secondary barriers), this is especially prominent in a fixed beam room as the radia-
tion will always be directed at the primary barrier as opposed to a gantry that distributes the
radiation over several primary barriers [42, 17].
The goal of shielding is to attenuate secondary radiation levels in order to keep them within
regulatory dose limits and protect against unreasonable radiation exposure. Table 5.3 lists the
factors that should be considered during shielding design. From a radiological perspective in a
radio-therapeutic setting, neutrons are the most significant as these are produced in prominent
numbers in beam line devices, patient and shielding, are scattered throughout the whole room
and have the potential to carry and deposit energy a significant distance away from their initial
induction site. Photons that arise in shielding due to neutron interactions are also of concern as
they may escape the shielding with sufficient energy to cause ionization events in tissue [18].
Shielding can be estimated over a wide range of thicknesses by combining the inverse
square law and exponential attenuation characterized by indirectly ionizing particles [18]
H(d, θ) =
Hθed(θ)/λ
r2
(5.0.3)
Where: H(d, θ) is the dose equivalent at depth d and angle θ in the shielding
Hθ is the dose equivalent term at production angle θ with respect to the incident beam
r is the distance between the target and point of interest outside the shield
λ is the effective attenuation length (attenuated by a factor of e) for dose equivalent through
the shield.
In idealized circumstances, assuming that each increment of barrier thickness reduces the ra-
diation by a constant factor, the transmission factor (T) of a barrier with thickness (x) may be
expressed as:
T(x) = e−x/λ (5.0.4)
These analytical models are however limited in their use and superseded by Monte Carlo
codes.
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Figure 5.3: Classification of the radiological areas in a particle therapy facility based on safety
concepts from the IAEA [17, p.85]
Table 5.3: Factors to be considered in shielding design[18]
ALARA Principle
Available Space
Comparison with other facilities
Construction Techniques
Environmental Radiation
Induced radioactivity
Radiation weighting factors
Radiation exposure history at the institution
Regulatory limits
Shielding materials
Trends in regulatory limits with time
Shielding Materials
Shielding must be comprised of enough material to effectively attenuate radiation of all ener-
gies and reduce the dose to acceptable levels. Materials of high atomic number and density
are valuable in shielding against photons as the photon cross sections increase strongly with
the Z of the material and the density of shielding ensure a high rate of interactions. Neu-
trons however, may attain energies that make them transparent to high-Z materials (Steel for
instance is transparent to 0˜.2-0.3 MeV neutrons) and require materials of low atomic number,
especially hydrogen, that are more efficient at slowing down and capturing neutrons [17]. The
most common radiation shielding materials are concrete and steel, with potential linings of
boron to reduce thermal neutrons in mazes or at critical locations [18]:
• Concrete has the advantage of being a relatively inexpensive and readily available shielding
material that can be poured into almost any configuration and used as structural support
for both the building and any additional shielding. Ordinary concrete without any supple-
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mentary materials has a density between 2.2 and 2.4 g/cm3 and provides shielding against
both photons, and neutrons, depending on the water content (5% water content is recom-
mended for neutron shielding) [17]. Water contains hydrogen and this makes it efficient
at slowing down fast neutrons (kinematically illustrated in chapter 2, section 2.3.1, equation
2.3.4) and at absorbing thermal neutrons due to its capture cross section, neutrons absorbed
by hydrogen will however emit a 2.22MeV photon and may therefore be a source of unin-
tended radiation and require additional gamma radiation shielding.
• Boron is sometimes introduced as linings (or by boronating concrete) and functions as
a more efficient and potentially safer neutron absorber with its, higher than hydrogen, ne-
utron capture cross section (as seen in chapter 2, figure 2.11) and that the neutron reaction
with boron emits an alpha that is stopped locally and a 0.48MeV photon.
• Steel (or iron) is often used when space is limited as it has a high density (∼ 7.4g/cm3)
and is an efficient shield against photons and fast neutrons. There is however a build-up of
low energy neutrons (< 1MeV) as the elastic scattering neutron cross section of materials
with high atomic number is too small to efficiently stop these. Steel must therefore be fol-
lowed by a hydrogenous material that can shield against low energy neutrons. Steel and
concrete are therefore commonly combined, where steel is constructed towards the source
and concrete is placed on the outside in order to remove these intermediate-energy neutrons
generated in steel.
Shielded Doors and Mazes
A movable shielded door can be used to provide access to a treatment room, but several prob-
lems arise with such a solution. The door must offer the same degree of safety and radiation
attenuation as the barrier that surrounds it, making it a very massive construction and impor-
tant that it operates reliably and safely. Cracks and gaps around the perimeter of a door must
be avoided to prevent leakage of scattered radiation, usually solved by overlapping shielding.
Each individual door must be given special attention and proper design as every installation
has its own unique configuration. This thesis will not go deeper into the design of a door, but
a simple shielded (iron) door will be compared to a maze configuration in the results chapter 7
Instead of having a massive shielded door, a maze can be used as an entrance to a treatment
room and is typically designed to avoid a direct propagation of radiation through a passage-
way, usually by having more than two maze legs that form one or more 90◦ bends as seen in
figure 5.4. In the design of a maze, two basic rules are of consideration: i) The sum of the
individual maze wall thicknesses should be equal to the thickness of the primary barrier. ii)
Placement of the maze should be so that the forward-scattered radiation from the target is not
directed towards it, implying that only a lower shifted energy distribution of secondary radia-
tion enters the maze.
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It is possible to analytically estimate the dose-equivalent inside a multi-legged mazes based
on experimental data from an Am-Be neutron source and a concrete maze [18, 17].
The dose-equivalent in the first leg, where there is a dramatic change in the radiation spectrum,
is essentially defined as an inverse square law with a scattering factor of two:
H(r1) = 2H0(r0)(r0/r1)2 . (5.0.5)
And the succeeding legs, where the subsequent radiation spectra are similar to one another, in
the form of two exponentials:
H(ri) =
(
e−ri/0.45 + 0.022A1.3i e
−ri/2.35
1+ 0.022A1.3i
)
H0i , ithleg(i > 1) , (5.0.6)
where for 5.0.5 and 5.0.6:
H0(r0) = dose equivalent at a point in the mouth
r0 = distance (in meters) from the source to the mouth of the labyrinth
r1 = center line distance (in meters) of the first maze leg
ri = center line distance (in meters) of the ith leg
Ai = cross sectional area of the maze (typically door sized 1mx2m)
H0i = dose equivalent at the entrance to the ith leg
So by increasing the length of the maze or decreasing the cross-sectional area will increase the
attenuation and thus lower the dose-equivalent.
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Figure 5.4: Example of a maze in a fixed beam treatment room where the walls are made of
normal concrete and five legs with four 90◦ bends. [18, 17]
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Chapter 6
The Monte Carlo Simulation Method
The Monte Carlo method is one of the most accurate and useful methods in computational
physics and can be used to evaluate and simulate particle transportation when analytical and
numerical calculations are impossible due to complicated geometries or the presence of too
many degrees of freedom. In essence, the Monte Carlo method creates a solution to a macro-
scopic system by simulating the system’s microscopic interactions [43].
Using probability distributions containing all physical processes and interactions that occur
at the atomic level and under (detailed in chapter 2), it becomes possible to follow and keep a
history of an individual particle’s energy and path through matter by randomly choosing an
event from the distribution. These probability distributions are obtained from experimental
measurements or from reliable models of particle transportation and aim to mimic the funda-
mental interaction processes that occur. For each step the particle takes, a new energy, direction
or path length value will be obtained until the particle gets absorbed, leaves the region of in-
terest or its energy falls below a user defined threshold, for this reason it is important to keep
the step size small in order get good resolution. The desired statistical precision and informa-
tion to be obtained will depend on the number of histories (N), as the error in Monte Carlo
calculations is proportional to 1/
√
N. The increase in computation time with increasing N is
also of importance as Monte Carlo simulations can be very data heavy and time consuming
[18, 44].
There are several Monte Carlo codes available concerning particle transportation, but this
thesis will only focus on FLUKA, a general purpose tool for calculations of particle transport
and interactions with matter. This Monte Carlo code will be detailed together with a summary
of the physical models behind it in the section below.
6.1 FLUKA
FLUKA is a multi-purpose transport Monte Carlo code capable of handling and simulating
about 60 different particles in a wide range of energies spanning from thermal energies (for
neutrons) or 0.1− 1 keV (for all other particles) up to thousands of TeV (20 TeV for hadrons
and neutrons) with high accuracy. It is widely used in basic physics research and has many
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applications in various fields including shielding design, dosimetry, radiotherapy, particle ac-
celerators, etc. FLUKA is based on microscopic models and conservation laws are enforced
at every step, this ensures a solid physical base and consistency among all reaction steps and
reaction types. Results are further benchmarked against experimental data, making the final
predictions with a minimal set of free parameters. All physical models are integrated into the
code and the user has limited means of tuning them [45, 46].
6.1.1 Physics and Models in FLUKA
The following is an excerpt from the FLUKA manual [46, p.4-7], detailing and summarising
the physical models, capabilities and limitations of FLUKA:
Hadron inelastic nuclear interactions;
Inelastic hadron-hadron cross sections are represented by parametrised experimental fits.
Interactions are simulated by the Dual Parton Model (DPM) for particles with momen-
tum < 20 TeV/c and > 5 GeV/c, and by resonance production and decay model from
threshold momentum to 5 GeV/c.
Inelastic hadron-nucleus interactions are simulated by Glauber-Gribov multiple scatter-
ing and Generalised Intranuclear Cascade (GINC) for particle momentums < 20 TeV/c
and > 5 GeV/c, and by the Preequilibrium-cascade model(PEANUT) below 5 GeV/c.
Elastic Scattering;
Parametrised nucleon-nucleon cross sections and tabulated nucleon-nucleus cross sec-
tions and phase shift data on pion-proton, as well as detailed kinematics of elastic scat-
tering on hydrogen nuclei and proton recoil transport.
Nucleus-Nucleus interactions;
DPMJET-II or DPMJET-II is used for energies above 5 GeV/u, between 0.125 and 5
GeV/u a modified Relativistic Quantum Molecular Dynamics (RQMD) model and be-
low 0.125 GeV/u the Boltzmann Master Equations (BME) is used.
Transport of charged hadrons;
Uses Bethe-Bloch theory with Mott correction to Rutherford scattering cross section and
shell and low energy corrections from Ziegler.
Optional delta-ray production and transport.
Ionisation potentials and density effects parameters from Sternheimer, Berger and
Seltzer.
Non-ionising energy losses (NIEL) and Displacements Per Atom (DPAs).
Special transport algorithm based on Molière’s theory of multiple Coulomb scattering
improved by Bethe.
Accurate treatment of boundaries and curved trajectories in magnetic and electric fields.
Path length correction and automatic control of the step.
Spin-relativistic effects at the level of the second Born approximation.
45
Nuclear size effects (scattering suppression) on option.
Fano correction for heavy charged particle multiple scattering.
Single scattering algorithm based on the Rutherford formula with a screening factor in
the form used by Molière, integrated analytically without any approximation, and nu-
clear form factors and spin-relativistic corrections at the first or second Born approxima-
tion level accounted for by a rejection technique.
Correction for cross section variation with energy over the step.
Bremsstrahlung and electron pair production at high energy by heavy charged particles,
treated as a continuous energy loss and deposition or as discrete processes depending on
user choice.
Muon photo nuclear interactions, with or without transport of the produced secondaries.
Low energy neutrons;
FLUKA uses its own neutron cross section library (multigroup P5) for energies lower
than 20 MeV and contains over 250 different materials that are of interest in physics.
Gamma-ray generation and different temperatures available and Doppler broadening
for temperatures above 0 K.
Transport uses standard multigroup with photon and fission neutron generation, de-
tailed kinematics of elastic scattering on hydrogen nuclei. Transport of proton recoils
and protons from N(n,p) reaction and capture photons are generated according to multi-
group treatment, but transported with the more accurate EMF package.
Photons;
Photoelectric effect with actual photo-electron angular distribution according to the fully
relativistic theory of Sauter.
Parameterisations/tabulations for photoelectric cross sections including all known edges
up to Z = 100 and down to a few eV.
Compton effect with Doppler broadening using a fit of the Compton profiles, and ac-
counts for atomic bonds through use of inelastic Hartree-Fock form factors.
Rayleigh scattering.
Pair production with actual angular distribution of electrons and positrons, including
Landau-Pomeranchuk-Migdal pair production suppression effect.
Photon polarisation taken into account for Compton, Rayleigh and Photoelectric effects.
6.1.2 FLUKA Geometry
For creating geometries, FLUKA uses an entirely rewritten and improved version of the Com-
binatorial Geometry (CG) package from MORSE with additional bodies like infinte planes and
cylinders. The user can define and combine "bodies" of various shapes and sizes and assign
materials to body defined "regions". This lets the user create and define complex and accurate
geometries such as detectors, therapeutic beam delivery systems, treatment rooms, etc [46].
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6.1.3 FLUKA Input
The interaction between FLUKA and users is based on text input files written in a standard
ASCII character encoding scheme with the file extension .inp and may contain the following
information [46]:
• Title and comments
• Description of the problem geometry
• Definition of the materials involved
• Material assignments
• Definition of the particle source
• Definition of requested detectors used to calculate physical quantities like dose, fluence,
etc.
• Definition of biasing schemes, problem settings such as energy cutoffs, step size, optional
physical effects, etc.
• Initialisation of the random number sequence, starting signal and number of requested
histories.
The user can directly define the type of beam particle, its energy (or momentum), starting
position and direction of the beam in these input files. Rarely is any programming required
from the user, but in the case of more complex beams (therapeutic beams), special user routines
can be written in Fortran 77 and linked to the input file.
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Chapter 7
Monte Carlo Simulations, Methods and Results
This chapter will describe the simulation setups defined in flair and run by FLUKA, as well
as describe their performance, motivation, and results. The FLUKA Monte Carlo code version
2011.2c-2, and flair - FLUKA Advanced Interface, version 2.1-7 was applied in all parts of this
thesis. The geometry editor in flair, Geoviewer was instrumental in the designing and relative
positioning of all geometries that make up the treatment rooms and phantoms in the simula-
tions. Processing and plotting of the simulation outcomes were also done in flair by utilizing
its incorporated Gnuplot environment.
The number of particles simulated in each simulation setup is guided by the work done
by J. Bauer et al, who evaluated Monte Carlo simulations with an analytical treatment plan-
ning system. They evaluated the number of simulated primary beam particles in Monte Carlo
simulations via a sensitivity study that depended on the fraction of simulated particles with
respect to the number of total particles in the treatment plan. Their results for achieving suf-
ficient Monte Carlo statistics with reasonable computation time, showed that 0.5− 1% of the
total number of treatment particles when applying protons, and at least 1% (up to 6%) of the
total number of carbon ions in a treatment fraction should be simulated 14. The number of
particles simulated in each setup in this project work are gathered in table C.1 in appendix ??.
Due to the high number of geometrical layouts and scoring situations in this project work,
eight different simulation set-ups for each of the three particles (24 simulations in total) were
designed and run separately with the intent of streamlining the execution of the simulations
with the computer resources available, and allowing the processing of the results to happen in
succession. Each simulation is identified by a "simulation name" as listed in table C.1 and the
individual simulation setups are further illustrated in Appendix ??, section C.2-C.8.
The comparative feature of this project work necessitates the determination of aspects and
variables that are to be kept constant and consistent across all simulations in order to nor-
malise the results and limit variations. This is realized by defining the treatment beam, dose
delivery and treatment room to have the same properties for all three particle types in all sim-
ulations. The treatment beam, treatment room and individual simulations defined for FLUKA
are detailed in section 7.1, 7.2 and 7.3 respectively. Results from the individual simulations are
processed and presented in section 7.4. Section 7.5 presents annual dose calculations and results
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to water equivalent phantoms outside the treatment rooms.
7.1 Definition of Therapeutic Treatment Beam
Kine Johnsen designed in her thesis "Simulations of a Therapeutic Proton Beam with FLUKA
Monte Carlo Code and Varian Eclipse Proton Planning Software" [22] an actively modulated
proton beam resembling a spot scanning system that aimed to deliver a homogeneous dose to a
target volume located at a defined depth inside a water phantom. This was achieved by editing
and linking a source.f user routine to the FLUKA input file. This user routine contains an energy
distribution and a set of weights that are randomly applied to the simulated primary beam
particles and subsequently form a SOBP covering the target volume longitudinally. The user
routine simultaneously defines initial beam particle positions that covers the target volume
laterally. This thesis builds upon the work performed by Kine Johnsen by editing the energy
distribution, weights and beam position for the three particles, proton, helium, and carbon.
The beams are defined to fully cover a 5× 5× 5cm3 Target Volume, located at the depth 15cm
to 20cm depth in a water phantom situated at a fixed position in the treatment room, with
a homogeneous physical treatment dose of 2Gy. The creation of the energy distribution and
weights for each of the beams in the source.f files that form the SOBP and longitudinal dose
coverage of the target, is based on the Bragg-Kleeman (BK) relationship between range and
energy of the particle in a material [8, 47],
R = αEp0 . (7.1.1)
E is the initial energy of the particle, α and p0 are material dependent constants. The α and
p0 parameters for proton, helium and carbon used in this project work are found in table 7.1
and were obtained from the work done by Wayne D. Newhauser and others, who fitted the
exponential BK rule to range curves and experimental data from proton, helium and carbon
ions over a wide range of energies [8].
To create a SOBP spanning a desired range, several successive beams of sequential energies
must be added together. The range of each of these contributing beams (k = 1, 2, ..., n) are
determined by the equation,
rk =
[
1−
(
1− k
n
)
χ
]
R0 , (7.1.2)
where R0 is the desired maximum depth, χ is the fraction of the maximum depth and width of
the SOBP, and n is the number of energy intervals involved [22]. By applying the ranges from
equation 7.1.2 to the BK rule 7.1.1, the corresponding energy of each beam (ek) in the SOBP are
obtained,
ek =
(
rk
α
) 1
p0
. (7.1.3)
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In order to achieve a flat dose plateau in the SOBP, the individual beams must be weighted such
that the proximal Bragg peak in the SOBP receives the lowest weight and the distal Bragg peak
receives the highest, as detailed in theory chapter 4, section 4.2. These beam weights wk are
calculated by the equation[22, 47],
wk =

1− (1− 12n )1−
1
p for k = 0
[1− 1n (k− 12 )]1−
1
p − [1− 1n (k + 12 )]1−
1
p for k = 1, ..., n− 1
( 12n )
1− 1p for k = n
. (7.1.4)
The parameter p will vary slightly with energy, depth and width of the SOBP as seen in K.
Johnsen’s work. The p values in table 7.2 have been found to give a sufficiently flat SOBP
plateau for this thesis.
The maximum range (R0) and SOBP width used in conjunction with equations 7.1.2, 7.1.3
and 7.1.4 to find the necessary energy range and corresponding weights needed to create a
SOB at a predefined depth, are listed in table 7.3. In this thesis, 50 equidistant beam energies
are applied and the maximum range for both the protons, helium and carbon ions, is set to ap-
proximately 20cm depth in water. In the FLUKA source.f file, the energies are listed as DATA
ENEDGE in GeV, and the weighting factors under DATA CUMPR. The user routines were
further edited with initial particle coordinates constructed to fully cover the target volume in
the lateral (x and y) directions.
* Particle coordinates [cm] that cover the volume in X and Y direction:
* Gaussian sigma 0.297(=0.7FWHM) to account for lateral spread of beam
*Proton:
CALL FLNRR2(RGAUS1, RGAUS2)
XFLK (NPFLKA) = (-3.43 + 0.297*RGAUS1)+ FLRNDM(DUMMY)*6.92
YFLK (NPFLKA) = (-3.445 + 0.297*RGAUS2)+ FLRNDM(DUMMY)*6.905
ZFLK (NPFLKA) = ZBEAM
The full details of the source.f files are found in appendix A.
Table 7.1: Fitting parameters α and p for water when applying the BK rule.
Particle type α p0
Proton 2.633x10−3 1.735
Helium 2.367x10−4 1.735
Carbon 5.605x10−5 1.545
Table 7.2: p-values used for calculating the beam weights.
Particle type p
Proton 1.6
Helium 1.54
Carbon 1.543
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Table 7.3: Predefined values R0 and SOBP width used to calculate the range and corresponding
energies.
Particle type Maximum range (R0) SOBP width Minimum energy Maximum energy
Proton 20.35 cm 5.085 cm 147.3 MeV 174.4 MeV
Helium 20.22 cm 4.8 cm 147.4 MeV/n 172.8 MeV/n
Carbon 20.04 cm 4.52 cm 280 MeV/n 331.5 Mev/n
Results
The resulting longitudinal and lateral dose profiles of the proton, helium, and carbon beam
defined in their source.f files, are displayed in figure 7.1, 7.2 and 7.3 respectively. The dose
plateau inside the target volume deviates no more than 4% from the set 100% (2Gy) level. A
measure of the physical dose coverage inside the target volume was obtained by measuring
the ratio between the volume covered by the 95% (1.9Gy) isodose line and the total volume of
the Target Volume,
V95
VTV
. (7.1.5)
The dose coverage achieved and listed in table 7.4 is within 0.5% for all three particle beams.
Table 7.4: Dose coverage factors and plateau deviations.
Plateau Deviation
Particle type Dose Coverage from 2Gy
Proton 0.995 1.2%
Helium 1.004 3.25%
Carbon 1.001 2.7%
To obtain a more clinically optimized dose deposition based on the sparing of healthy tissue
and the effect of the higher RBE of helium and carbon ions, a designated Treatment Planning
Software such as Eclipse (Varian) should be used. The goal of this thesis however, is not to
make clinically optimized treatment plans and the transition from physical to effective dose in
the Target Volume is an normalization aspect not applied in this work. The dose deposition
is instead normalized to a physical dose of 2Gy and the 95% coverage factor of 1.000± 0.005
are kept consistent through all simulations in this project work. The normalization to 2Gy is
done by determining the number of primaries that are needed in a single treatment fraction to
achieve 2Gy in the SOBP plateau. Simulation results obtained from FLUKA are intrinsically
normalized to per primary and by studying the dose profile plots and the FLUKA calculated
integral of total energy deposited per primary in a projection covering the Target Volume, the
number of primaries in a single treatment fraction delivering 2Gy was obtained and collected
in table 7.5.
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Table 7.5: Number of Primaries in a treatment fraction delivering 2 Gy to the CTV.
Particle type # of primaries in a
treatment fraction
Proton 5.814E10
Helium 1.34E10
Carbon 2.268E8
(a) Depth dose profile along the central beam axis for protons with energies 147-174 MeV. The Target
Volume covered by the dose is located at the 15cm-20cm range.
(b) Lateral dose profile of treatment protons, the Target Volume is located at the −2.5cm to 2.5cm range.
Figure 7.1: The longitudinal dose profile (a) and lateral dose profile (b) of the actively modu-
lated proton beam defined in the source.f user routine and simulated in FLUKA.
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(a) Depth dose profile along the central beam axis for helium ions with energies 147-173 Mev/n. The
Target Volume covered by the dose is located at the 15cm-20cm range.
(b) Lateral dose profile from helium, the Target Volume is located at the −2.5cm to 2.5cm range.
Figure 7.2: The longitudinal dose profile (a) and lateral dose profile (b) of the actively modu-
lated helium beam defined in the source.f user routine and simulated in FLUKA.
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(a) Depth dose profile along the central beam axis for carbon ions with energies 280-331.5 MeV/n. The
Target Volume covered by the dose is located at the 15cm-20cm range.
(b) Lateral dose profile from carbon, the Target Volume is located at the −2.5cm to 2.5cm range.
Figure 7.3: The longitudinal dose profile (a) and lateral dose profile (b) of the actively modu-
lated carbon beam defined in the source.f user routine and simulated in FLUKA.
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7.2 Creation of Treatment Room in FLUKA
The treatment room is modelled after a technical drawing of a two gantry treatment room
(SC360, model version D0001177) setup from ProNova Solutions, a status report on the
MedAustron project (an Austrian ion therapy and research centre) [48], public images of a
fixed beam treatment room at the Heidelberg Ion-Beam Therapy Center (HIT) [49] and the
treatment room model used in the project thesis of John Alfred Brennsæter [50]. The treatment
room set up in FLUKA’s Geoviewer application, and used as the foundation for all simulation
set-ups featured in this thesis, is illustrated in figure 7.4 and has the following dimensions;
1300cm along the z-axis (length), 880cm along the x-axis (width) and 450cm along the y-axis
(height). The room is filled with air and surrounded by 200cm thick concrete walls on all sides
except for a 400cm thick forward facing wall (primary barrier). The direction of the simulated
beam is always along the positive Z-axis (parallel to the floor and flank walls) and starts at
position 0, 0,−100cm (1m before the water phantom functioning as the patient). No additional
beam components, such as those discussed in chapter 4, figure 4.4, panel (b), are introduced
into the beam line in this project work.
A liquid water phantom modelled after an average adult human torso (70× 20× 40cm3 [4])
functions as the patient and has its isocenter placed 120cm above the floor, 480cm away from
the primary barrier and 440cm from the two flank walls. Several other water phantoms (named
Worker1,2,3 and 4) with the same proportions as the patient phantom (40× 70× 20cm3) are
placed in the upright position at key scoring locations in the different simulation setups where
relevant. A relevant simulation layout is shown in figure 7.5 and illustrates how the worker
phantoms are arranged. All simulation geometries and layouts created for this thesis are de-
tailed in appendix ??, and densities and molecular contents of all materials involved are listed
in appendix B.
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(a) Two dimensional layout of the basic treatment room as set up in Geoviewer and viewed along the
y-axis (top-down view).
(b) Two dimensional layout drof the basic treatment room as set up in Geoviewer and viewed along the
x-axis (side view).
Figure 7.4: Two dimensional layouts of the basic treatment room viewed along the (a) y-axis
and (b) x-axis.
Figure 7.5: Two dimensional layout of the "RightMaze" setup as viewed along the y-axis (top-
down view).
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7.3 FLUKA Simulations
Each of the eight individual simulation setups used in this project work are detailed in ap-
pendix C, and two-dimensional layouts are found in their respective sections C.0.1-C.0.8. The
computing resources available made it possible to run a total of six simulations simultaneously
where each run would take approximately 90 hours to complete. Every simulation was per-
formed with proton, helium, and carbon ions separately for a total of individual 24 simulation
runs, the number of simulated primaries in each simulation are listed in table C.1 in appendix
C. In this project work each simulation setup is identified and referred to by an "identification
name".
"WaterPhantom"(appendix C.0.1) and "ClosedRoom" (appendix C.0.2) were created and
performed in order to score the secondary particle production induced in the interac-
tions between the treatment beam and treatment phantom. Fluence scoring detectors
and regions were designed to give insight into the effect of back scattered particles of
off treatment room walls by assessing the difference in dose and fluence entering the
treatment phantom, both with and without surrounding walls.
"RightMaze" (appendix C.0.3) was built with a zigzagged maze made of four 90◦ bends and
functions as the entrance to the treatment room, the maze was placed inside the primary
barrier. The sub-geometry "RightMazeBoron" (appendix C.0.4) considers an identically
placed maze, but with two added boron layers located inside the last two maze arms.
"MiddleMaze" (appendix C.0.5) has a pure concrete maze with the same proportions and
dimensions as the maze in "RightMaze", but is located inside the right flank wall of the
treatment room.
MiddleDoor (appendix C.0.6) considers a straight corridor through the right flank wall and
separates the inside and outside of the treatment room with a 100cm thick iron door.
PrimaryBarrier (appendix C.0.7) focuses on the 400cm thick forward facing primary barrier
made of pure concrete.
BeamDump (appendix C.0.8) considers the dumping of the treatment beam into a 30cm tick
steel layer covering the first part of the primary barrier.
In order to assess the dosimetric consequences of the changes in the entrance geome-
tries and through the introduction of shielding materials, water equivalent phantoms called
Worker1, 2, 3 and 4 were placed at various locations inside and outside the structures of inter-
est. Their exact locations are shown and detailed in the individual simulation layouts found
in their respective layout sections in appendx C. Each worker phantom has dose scoring de-
tectors measuring their respective effective doses associated with them. These scoring de-
tectors implements fluence conversion factors based on the 2007 recommendations from the
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ICRP, and outputs the effective dose in pSv/primary. Each result is manually normalised to
mSv/treatment f raction and illustrated as bar charts with a logarithmic y-axis in applicable
parts of the results found in section 7.4. Detailed results and error bars associated with the
effective doses are gathered in appendix F, table F.1.
Differential fluence spectrum of particles entering and exiting specific structures, with an
emphasis on photons and neutrons due to their penetrative properties, were scored and plotted
in an isolethargic manner. This means that the differential fluence spectra are plotted as,
dΦ
d(logE)
= E
dΦ
dE
. (7.3.1)
Such plots were chosen due to the fact that isolethargic spectra plotted with a logarithmic x-
axis and linear y-axis, ensures that the area under the curve between two points log(x1) and
log(x2) are proportional to the integral of E(x) resulting in an intuitive and informative plot
of the energy distribution and corresponding fluence. In addition, 2-dimensional colour plots
of particle fluence through specific structures are added for the sake of visualising particle
paths and fluence intensity in a bin by bin basis, but note that unless specified otherwise, all
2-dimensional colour plots are from the carbon treatment beam. The carbon beam was chosen
for this for having the highest energy and fluence activity compared to the proton and helium
treatment beam. It should be noted that all isolethargic fluence plots are shown with error bars
for either Carbon and helium exclusively, this was done for the sake of readability. Error bars
that are omitted are of the same order as the error bars plotted unless specified otherwise in
the figure caption.
7.4 Results
WaterPhantom and ClosedRoom
In the "WaterPhantom" simulation (layout drawing C.0.1 in appendix C.0.1) a scoring region
was placed on the back-side of the patient phantom (towards the primary barrier) in order to
score the differential fluence of selected secondary particles exiting towards the primary bar-
rier. This same scoring region was applied to simulation "ClosedRoom" (layout drawing C.0.2,
appendix C.0.2) in order to score the differential fluence of neutrons and photons entering the
patient phantom due to backscattering off of the primary barrier. Resulting isolethargic differ-
ential fluence of neutrons and photons exiting and entering the patient phantom are found in
figure ?? and 7.7 respectively. Figure 7.6, panel (a) show that the majority of neutrons exiting
are fast neutrons. Panel (b) in the same figure show the energy spectrum of neutrons entering
the backside of the patient phantom and an elevated thermal peak is noted. Figure 7.7, panel
(a) and panel (b) show photons exiting and entering the backside of the patient phantom re-
spectively. Some characteristic photon peaks are observed, notably the characteristic 511keV
photo-peak from electron-positron annihilation and the 2.2MeV photon peak characteristic of
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hydrogen neutron capture. Additional plots of secondary protons, helium 4 and heavy ions
exiting the patient phantom for each of the three treatment beams are found in appendix D, fig-
ure ??. Fluence of backscattered protons, helium and heavy ions entering the patient phantom
are negligible.
In addition to the differential fluence spectrum of secondary particles exiting and enter-
ing the backside of the patient phantom for each of the three treatment beams, a comparison
of the absorbed dose and fluence inside the patient phantom from some selected secondary
particle types, was made. This was performed in order to investigate the difference in dose
to the patient phantom with the inclusion of surrounding walls ("ClosedRoom"). The results
displaying the absorbed dose and composite fluence spectra inside the patient phantom are
listed in appendix E, table E.1 and table E.2 respectively. The results show that there is less
than 0.3% increase in neutron fluence and 0.8% photon fluence in the patient phantom when
there are walls present. The change in absorbed dose to the patient phantom is observed to be
approximately zero.
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(a) Isolethargic differential fluence spectrum of neutrons exiting the backside of the patient
phantom. Error-bars are omitted completely from the figure for the sake of readability as
they are too small to be effectively read
(b) Isolethargic differential fluence spectrum of neutrons entering the back-side of the pa-
tient phantom. Results are corrected for neutrons entering the phantom when there are no
walls.
Figure 7.6: Panel (a) shows the energy distribution of neutrons exiting the patient phantom.
Panel (b) shows the energy distribution of neutrons entering the patient phantom.
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(a) Isolethargic differential fluence spectrum over photons exiting the patient
phantom in the forward direction. Error-bars are omitted completely from the
figure for the sake of readability as they are too small to be effectively read
(b) Isolethargic differential fluence spectrum of photons entering the back-side
of the patient phantom.
Figure 7.7: Panel (a) show the energy distribution of photons exiting the patient phantom and
panel (b) show the energy distribution of photons entering the patient phantom.
RightMaze and RightMazeBoron
The two simulation setups "RightMaze" and "RightMazeBoron" were designed to yield infor-
mation about the secondary particle and dose production in a region around around an en-
trance maze with and without the presence of boron layers for shielding purposes. Simulation
setup "RightMaze" contains a maze made only of concrete, a two-dimensional layout drawing
can be studied in appendix C.0.3, figure C.3. The simulation setup "RightMazeBoron" (two-
dimensional layout drawing can be studied in appendix C.0.4, figure C.0.4) includes two 10cm
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thick boron layers located in each of the two inner maze arms. Besides the boron shielding,
the two simulation setups are identical. Three water phantoms (Worker1-3) were placed inside
the maze next to each of the three maze arms, while a fourth (Worker4) was placed outside the
last arm of the maze. Effective doses were scored in each of these phantoms and visualised as
two a bar charts in figure 7.8. Panel (a) displays the effective dose to worker1-4 in simulation
"RightMaze" and panel (b) in "RightMazeBoron".
(a) Bar Chart Illustrating Effective Dose to
Workers1-4 in simulation "RightMaze"
(b) Bar Chart Illustrating Effective Dose to
Workers1-4 in simultion "RightMazeBoron"
Figure 7.8
Additionally, a fluence detector covering the entirety of the maze and scoring the fluence
of neutrons, photons and protons was placed and the results plotted in order to gain insight
into the effect of the boron layers on the neutron fluence, and simultaneously observe how
particles, especially neutrons and photons, behaved inside the maze. Differential isolethargic
fluence plots of secondary neutrons and photons entering the maze hallway is approximately
identical in both simulation setups and are therefore only plotted for the "RightMaze" setup in
figure 7.9. Panel (a) shows the neutron spectrum and panel (b) the photon spectrum entering
the maze hallway. The isolethargic differential fluence and two-dimensional fluence plots of
neutrons and photons exiting and travelling through the maze hallway for the two simulation
setups are presented in figures 7.10 and 7.11 respectively. A decrease in the number of neutrons
and photons exiting the maze hallway with boron layers are noted.
The same quantities are plotted for protons entering and exiting the maze hallway and
are shown in figure 7.12. The results of protons, and to an extent, the heavier ions exiting
the maze hallway, show little activity and this is observed to the same degree in all other
simulation setups presented in this thesis. Fluence plots of secondary protons and heavier
ions are therefore omitted and only fluence plots concerning secondary neutrons and photons
will be presented in the coming simulation results.
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(a) Differential isolethargic fluence plot of secondary neutrons entering the maze
hallway in "RightMaze".
(b) Differential isolethargic fluence plot of secondary photons entering the maze hall-
way in "RightMaze".
Figure 7.9
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(a) Two-dimensional fluence plot of secondary neutrons inside the
maze in simulation setup "RightMaze" when the carbon beam is ap-
plied.
(b) Two-dimensional fluence plot of secondary neutrons inside the
maze in simulation setup "RightMazeBoron" when the carbon beam is
applied.
(c) Isolethargic differential fluence plot of secondary neutrons exiting
the maze hallway in simulation setup "RightMaze".
(d) Isolethargic differential fluence plot of neutrons exiting the maze
hallway in simulation setup "RightMazeBoron".
Figure 7.10
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(a) Two-dimensional fluence plot of photons inside the maze in simula-
tion setup "RightMaze" when the carbon beam is applied.
(b) Two-dimensional fluence plot of photons inside the maze in simula-
tion setup "RightMazeBoron" when the carbon beam is applied.
(c) Isolethargic differential fluence plot of neutrons exiting the maze
hallway in simulation setup "RightMaze".
(d) Isolethargic differential fluence plot of neutrons exiting the maze
hallway in simulation setup "RightMazeBoron".
Figure 7.11
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(a) Isolethargic differential fluence spectrum of protons entering
the maze hallway in simulation setup "RightMaze".
(b) 2-dimensional fluence plot of protons inside the maze in simulation setup
"RightMaze" when the carbon beam is applied.
(c) Isolethargic differential fluence plot of protons exiting the
maze hallway in simulation setup "RightMaze".
Figure 7.12
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MiddleMaze
The last simulation concerning a maze functioning as an entrance ("MiddleMaze") is centred
around a maze with the same dimensions as the maze found in "RightMaze", but is instead
placed in the middle of the right flank wall of the treatment room (layout drawing is found in
appendix C.0.5). The same water phantoms (Worker1-4) were placed at similar locations inside
the maze and consequently scored for effective dose while irradiating the patient phantom
with protons, helium and carbon ions. The results are illustrated as a bar chart in figure 7.13
below and detailed results and error bars associated with the effective doses are gathered in
appendix F, table F.1.
Figure 7.13: Bar chart showing the effective dose [mSv/treatment fraction] to worker1-4 lo-
cated inside and outside the maze.
Isolethargic differential fluence plots of secondary neutrons and photons entering and exiting
the maze hallway together with two-dimensional fluence plots inside the maze are found in
figure 7.14 and figure 7.15 for neutrons and photons respectively. Error bars are plotted for
the carbon beam and the others are omitted for the sake of readability, but the error bars for
helium and protons are of the same order, except for the single 155MeV proton spike where
the y-axis error is ±1000.
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(a) Isolethargic differential fluence spectrum of neutrons entering
the maze hallway in simulation setup "MiddleMaze".
(b) 2-dimensional fluence plot of neutrons inside the maze in simulation setup
"MiddleMaze" when the helium beam is applied.
(c) Isolethargic differential fluence spectrum of neutrons exiting
the maze hallway in simulation setup "MiddleMaze".
Figure 7.14
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(a) Isolethargic differential fluence spectrum over neutrons enter-
ing the maze hallway in simulation setup "MiddleMaze".
(b) 2-dimensional fluence plot of photons inside the maze in simulation setup
"MiddleMaze" when the helium beam is applied.
(c) Isolethargic differential fluence spectrum of photons exiting
the maze hallway in simulation setup "MiddleMaze".
Figure 7.15
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MiddleDoor
A simulation setup connected to the "MiddleMaze", but instead of a maze, a corridor with
a 100cm thick iron door in the middle is placed inside the right flank wall of the treatment
room (layout drawing is seen in figure ??, appendix C.0.6). Two water phantoms (Worker3
and Worker4) were placed at two locations on the other side of this flank wall, one close to the
door and one further away. The effective doses to these phantoms are found in table F.1 in the
appendix F and illustrated as a bar chart in figure 7.16.
Figure 7.16: Bar chart showing the effective dose [mSv/treatment fraction] to worker3 and 4
located on the outside of the treatment room.
Isolethargic differential fluence spectrum of neutrons and photons entering and exiting the cor-
ridor, together with two-dimensional fluence plots of neutrons and photons inside and around
the corridor are found in figures 7.17 and 7.18 respectively.
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(a) Isolethargic differential fluence spectrum over neutrons enter-
ing the corridor in simulation setup "MiddleDoor".
(b) Two-dimensional fluence plot of neutrons inside the corridor in simulation
setup "MiddleDoor" when the carbon beam is applied.
(c) Isolethargic differential fluence spectrum of neutrons exiting
the corridor in simulation setup "MiddleDoor".
Figure 7.17
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(a) Isolethargic differential fluence spectrum over photons enter-
ing the corridor in simulation setup "MiddleDoor".
(b) Two-dimensional fluence plot of photons inside the corridor in simulation
setup "MiddleDoor" when the carbon beam is applied.
(c) Isolethargic differential fluence spectrum of photons exiting
the corridor in simulation setup "MiddleDoor".
Figure 7.18
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PrimaryBarrier
A simulation focused entirely on the primary barrier was performed (layout drawing is found
in figure C.7, appendix C.0.7), where a single water phantom (Worker4) was placed 50cm from
the concrete wall in the central beam axis outside the treatment room for the sake of measuring
the resulting effective dose while irradiating the patient phantom with proton, helium and
carbon respectively, the results are shown in the bar chart in figure 7.19.
Figure 7.19
Due to their penetrative properties, neutron and photon fluence plots, in both one- and two-
dimensions, together with isolethargic differential fluence plot of neutrons and photons exiting
the primary barrier, were scored and shown in figure 7.20 and 7.21 for neutrons and photons
respectively. A50cm× 50cm projection limit in x- and y-direction centred around the isocenter
was chosen in the one dimensional fluence plots in order to focus on the the maximum flu-
ence within the barrier. In all two dimensional plots, a 100cm thick y-projection slice, centred
around the isocenter and thus covering the maximum fluence, was chosen.
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(a) Neutron fluence plotted in 1-dimension with respect to the
primary barrier depth ("PrimaryBarrier").
(b) Two-dimensional fluence plot of neutrons inside the primary barrier in
simulation setup "PrimaryBarrier" when the carbon beam is applied.
(c) Isolethargic differential fluence spectrum of neutrons exiting
the primary barrier in simulation setup "PrimaryBarrier" for each
of the three treatment beams.
Figure 7.20
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(a) Photon fluence plotted in one-dimension with respect to the
primary barrier depth ("PrimaryBarrier").
(b) Two-dimensional fluence plot of photons inside the primary barrier in sim-
ulation setup "PrimaryBarrier" when the carbon beam is applied.
(c) Isolethargic differential fluence spectrum of photons exiting
the primary barrier in simulation setup "PrimaryBarrier" for each
of the three treatment beams.
Figure 7.21
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BeamDump
The last simulation aimed at the primary barrier focused on a beam dump aspect ("Beam-
Dump", layout drawing is found in figure C.8, appendix C.0.8. The two main differences be-
tween this simulation and "PrimaryBarrier" is the absence of a patient phantom, and the inclu-
sion of a 30cm steel layer covering the first 30 centimetres of the primary barrier. Similarly as
in the "PrimaryBarrier" simulation, a single water phantom (Worker4) was placed outside the
room on the opposite side of the primary barrier in order to measure the effective dose shown
in figure 7.22.
Figure 7.22: Effective dose to Worker4 in "BeamDump" simulation [mSv/Treatment fraction]
Fluence plots in one- and two-dimensions, together with isolethargic differential fluence plots
of neutrons and photons exiting the primary barrier, were scored and shown in figure 7.23 and
7.24 respectively. Same as in the "PrimaryBarrier" setup, a 50cm× 50cm projection limit in x-
and y-direction centred around the isocenter was chosen in the one dimensional fluence plots
and in all two dimensional plots, a 100cm thick y-projection slice centred around the isocenter
was chosen.
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(a) Neutron fluence plotted in one-dimension with respect to the
primary barrier depth ("BeamDump").
(b) two-dimensional fluence plot of neutrons inside the primary barrier in sim-
ulation setup "BeamDump" when the carbon beam is applied.
(c) Isolethargic differential fluence spectrum of neutrons exiting
the primary barrier in simulation setup "BeamDump" for each of
the three treatment beams.
Figure 7.23
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(a) Photon fluence plotted in one-dimension with respect to the
primary barrier depth ("BeamDump").
(b) Two-dimensional fluence plot of photons inside the primary barrier in sim-
ulation setup "BeamDump" when the carbon beam is applied.
(c) Isolethargic differential fluence spectrum of photons exiting
the primary barrier in simulation setup "BeamDump" for each of
the three treatment beams.
Figure 7.24
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7.5 Annual Dose to Outside Workers
In each simulation, one or two worker phantoms were placed outside the treatment room.
Worker3 was typically placed inside or close to the entrance of the geometrical structure of
interest and Worker4 was located outside and behind walls. Exact positions are shown in the
respective appendix C sections. Each of these two workers had an effective dose scoring detec-
tor associated with them. FLUKA calculates these by using its integrated fluence conversion
factors based on the 2007 ICRP recommendations. These effective dose measurement were
used in calculations of the workers anual dose, based on an assumption that a single treatment
room would be used for 25 treatments (each delivering a physical dose of 2Gy) per day, 235
days per year. The effective dose each phantom receives per year [mSv/year] in each simula-
tion setup is calculated and presented in table 7.6 below.
Table 7.6: Calculated annual dose to Workers outside the treatment room for each treatment
beam in each individual simulation setup.
Simulation Setup Particle Type Workload to Workload to
Worker3 [mSv/year] Worker4 [mSv/year]
Proton 0.024±0.001 0.005±5.0E-4
RightMaze Helium 0.054±0.001 0.015±9.7E-4
Carbon 0.186±0.003 0.07±0.0035
Proton 0.023±0.001 0.006±6.1E-4
RightMazeBoron Helium 0.054±0.002 0.014±8.5E-4
Carbon 0.186±0.003 0.07±0.003
Proton 0.01±7.6E-4
MiddleMaze Helium 0.02±5.3E-4 Not Present
Carbon 0.03±0.001
Proton 7.6E-4±7.9E-5 3.5E-5±1.8E-5
MiddleDoor Helium 0.001±1.1E-4 2.0E-4±1.0E-4
Carbon 0.003±0.0015 5.5E-4±1.7E-4
Proton 3.0E-4±2.3E-4
PrimaryBarrier Helium Not Present 0.008±4.2E-4
Carbon 0.06±0.003
Proton 6.21E-4±1.5E-4
BeamDump Helium Not Present 0.007±8.3E-4
Carbon 0.05±1.6E-3
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Chapter 8
Discussion and Outlook
Precise estimates and calculations of induced secondary particles with its associated genera-
tion of unwanted dose to the patient and hospital personnel is a key element in the planning
stages for a particle therapy facility. The motivation for this master thesis work is to obtain
generic, but precise, information about the radiation environment in the main area for such
dose production, in the treatment room and in the entrance area and corridors surrounding
this.
The focus of this master thesis work has been to perform comparative studies of the sec-
ondary dose production while irradiating a phantom patient with a standard physical dose
(2Gy) from protons, helium and carbon ions. Studies of different, realistic, geometries and
locations for the entrance part of the treatment room. By placing water equivalent phantoms
representing hospital personnel at several positions in the treatment room entrance region and
scoring the effective dose to these phantoms, estimates of the dose received to these positions
during a treatment fraction and during a treatment year, with some assumptions concerning
the number of fractions per year, can be applied to further investigate and improve the design;
shapes, barrier thickness, relative positioning and overall layout of the treatment facility.
Studies of the secondary particles produced when high energetic nuclear particles in the
treatment beam interacts with matter were performed and followed up by differential fluence
studies of neutrons and photons entering and exiting the featured geometrical structures in
order to chart the dose environment during irradiation. The FLUKA Monte Carlo Simulation
code allows the creation of relatively comprehensive and realistic treatment room geometries
that can incorporate different types of entrance geometries and primary shielding barriers.
Emphasis has been put on the radiation environment in three positions inside a standard en-
trance maze, both with and without layers of boron for additional neutron shielding, located
inside the two inner maze arms. And a third maze of identical proportions placed inside the
flank wall. A straight corridor geometry with an iron door in the middle, placed in the flank
wall of the treatment room was also defined and studied, before introducing a steel layer to
the primary barrier and performing a beam dump.
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Three different treatment beams made of protons, helium and carbon ions were created to
cover a Target Volume inside a patient phantom via an active energy modulation scheme as
presented in chapter 7, section 7.1. The dose plateau of the SOBPs were designed in order to
be sufficiently flat and no additional attempts at optimizing the treatment plans outside the
dose coverage were made. The dose coverage and the delivery of a physical dose of 2 Gy to
the Target Volume was applied as the normalization between the three treatment particle types
and the dose coverages obtained were estimated to be satisfactory for the purposes and inten-
tions of this comparative study. However, it is quite important to note that the higher RBE of
helium and carbon ions, with respect to the biological efficiency of protons, are not accounted
for and this effectively increased the number of treatment particles to a higher number than
what would otherwise be the case in a clinical setting. The main reason for working with phys-
ical dose is that it would be outside of the scope of this thesis project to introduce modelling
of biological doses to tissue, as this is still a quite open field with relatively large uncertain-
ties associated with the models applied for quantification of the biological effect from particle
therapy. However, from a radiation shielding point of view, the number of helium and carbon
ions applied in this work can be thought of as a "worst"case scenarios and is considered as such.
A total of 24 simulation setups covering eight different treatment room layouts for each of
the three treatment particles were constructed with flair and performed with application of
the FLUKA Monte Carlo simulation tool. The additional dose to the patient phantom from the
concrete walls surrounding the treatment room was studied in the simulations named "Closed-
Room" and the precense of the walls yielded a small, < 1%, increase in the photon and neutron
fluence inside the patient phantom when scoring the fluence during irradiation with and with-
out the walls present. However, no noticeable increase in the dose to the patient phantom was
observed. Secondary neutrons, photons, and charged particles produced through interactions
between the patient phantom and proton, helium, and carbon beams respectively, was ob-
served to contain secondary particles with energies up to the initial beam energy. Due to the
fragmentation and the considerably higher initial beam energy of the carbon beam, with 12
nucleons carrying the kinetic energy required to reach the same depth as the single protons
and the helium ions, the largest amount of secondary neutrons, photons, protons and heavier
ions were produced during carbon ion irradiation of the Target Volume. At the same time,
during carbon ion irradiation, attaining the widest energy spectrum when compared to the
helium and proton beam spectra. This implies that the scaling of the radiation shielding in
a treatment room where proton, helium, and carbon ion beams will be applied, must have
its origin in shielding towards carbon ion induced secondary particle production in order to
ensure adequately shielding. Generally, it is observed that neutrons and photons are the parti-
cles with the largest penetrative power. Neutrons and photons exit the treatment room in high
numbers compared to charged particles like protons and heavier secondary ions. Due to this,
differential neutron- and photon fluence scoring layers were placed at entrances and exits of
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the studied geometries.
The obtained results for the effective doses to water phantoms displayed little variation
between the different simulation setups. Of the four different entrances, the 100cm thick iron
door ("MiddleDoor") located in the right flank wall, yielded the least amount of effective dose
to a worker located on the outside of the door. Concurrently, the maze ("MiddleMaze") located
at the same position, resulted in the least amount of dose when compared to the two mazes
located inside the primary barrier. These results lead to the observation that there is a clear
benefit of locating the entrance to a treatment room in the perpendicular direction with respect
to the beam line direction. This is observation is supported by the what one will find when
collecting information based upon several particle therapy facility layout drawings. Differen-
tial fluence spectra of neutrons entering a hallway placed inside a flank wall, when compared
to a hallway inside the primary barrier, showed significantly fewer fast neutrons and thus ef-
fectively lessening the shielding burden and dose deposition. For all the different simulation
geometry setups, the annual effective doses to worker phantoms located in different positions
outside the treatment room, were obtained. The annual effective doses to these worker phan-
toms were found to be several orders of magnitude lower than the annually allowed dose of
1mSv to the public and, more importantly, the obtained effective doses are far lower than the
annually allowed dose of 20 mSv to the personnel working at a radiation treatment facility.
The possibility of optimizing the geometry, material compositions, thicknesses, sizes and
relevant positioning of beam the line area, the treatment rooms, the patient area and the work-
flow for the personnel at a particle therapy facility through Monte Carlo Simulations is very
important. The results from the Monte Carlo studies from this master thesis work will hope-
fully contribute to shed light and insight onto further investigations on this important aspect
of the overall planning and building of particle therapy facilities in Norway.
Future Outlook
FLUKA is a powerful and versatile Monte Carlo simulation tool for general shielding appli-
cations. This project offers a generic foundation for future simulations and correlated exper-
iments from which one can expand and further to create a data base applicable for detailed
studies of the production of secondary particles and the corresponding generation of sec-
ondary dose to both the patients and the personnel at a particle therapy facility. The possi-
bility of studying the effect of performing changes to the geometry and layout in advance of
the actual building stage of a facility is very important, both with respect to minimization of
unwanted particle production and with respect to pre-determination of which areas of a facil-
ity that requires special attention when performing the finalization of the radiation shielding
design.
Among many of the challenges to be addressed in subsequent proton, helium, and carbon
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beam simulations and shielding experiments we here list:
• In order to better approximate a clinical particle therapy treatment situation, apply the sim-
ulated distributions of equivalent dose in units of Sv, that take into account the higher RBE of
helium and carbon ions should be implemented and used for normalization purposes.
• Introduce beam line components into the beam line; in the case of a spot scanning system, a
detailed scanning nozzle with an ionization chamber and vacuum window.
• A rotating gantry moving the treatment beam around the patient that is creating new shield-
ing modelling scenarios that demand further examinations and considerations regarding the
treatment room and shielding barriers.
• Benchmark dose measurements in FLUKA with experimental data from an existing treat-
ment facility that adequate dose surveillance system in place and simultaneously offering de-
tailed drawings of building structures. This can be used as measurement verification in con-
junction with simulation optimization.
• Study the secondary particle and dose production when applying other particle species than
those in this master thesis study.
• Optimize FLUKA simulations with improved biasing regions and longer run times.
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Appendix A
FLUKA Script
A.1 Input Cards
The FLUKA input card for creating a treatment room with a maze (RightMaze) and defining
scoring detectors that determine dose in the worker (water) phantoms and differential fluence
inside the maze region.
TITLE
* Set the defaults for precision simulations
DEFAULTS PRECISIO
* Define the beam characteristics
BEAM -0.2 -0.0 -0.0 0.0 -0.0 PROTON
* Define the beam position
BEAMPOS -100.0
SOURCE
GEOBEGIN COMBNAME
3 0
* Black body
SPH blkbody 0.0 0.0 0.0 100000.0
* Void sphere
SPH void 0.0 0.0 0.0 10000.0
SPH air 0.0 0.0 0.0 2500.0
RPP BIASBOX -440.0 35.0 -120. 130. 40. 500.
RPP phantom -35. 35. -10. 10. 0.0 40.
RPP innerBox -440. 440. -120. 330. -800. 500.
RPP outerBox -640. 640. -320. 530. -1000. 900.
RPP Worker1 -360. -320. -35. 35. 530. 550.
RPP Worker2 -520. -480. -35. 35. 690. 710.
RPP Worker3 -360. -320. -35. 35. 850. 870.
RPP Worker4 -520. -480. -35. 35. 940. 960.
RPP mazeShie -640. -200. -320. 530. 500. 900.
RPP exit -380. -300. -120. 80. 500. 660.
RPP L1 -540. -380. -120. 80. 580. 660.
RPP L2 -540. -460. -120. 80. 660. 740.
RPP L3 -540. -300. -120. 80. 740. 820.
RPP enter -380. -300. -120. 80. 820. 900.
RPP OutAir1 -700. -100. -220. 330. 900. 1000.
RPP OutAir2 -700. -640. -220. 330. 400. 900.
END
* Black hole
BLKBODY 5 +blkbody -void
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* Void around
VOID 5 +void -air
* Air around the treatment room
AIR 5 +air -outerBox -mazeShie -OutAir1 -OutAir2
* Air around the treatment room
ROOMAIR 5 +innerBox -BIASBOX -phantom
* Walls region
WALLS 5 +outerBox -BIASBOX -innerBox -mazeShie
* Walls region
MAZESHIE 5 +mazeShie -exit -L1 -L2 -L3 -enter -OutAir1 -OutAir2
* Air inside the treatment room
BIASBOX 5 +BIASBOX +innerBox -phantom
* Phantom target
PHANTOM 5 +air +phantom -BIASBOX
WORKER1 5 +Worker1 +exit
WORKER2 5 +Worker2 +L2
WORKER3 5 +Worker3 +enter
WORKER4 5 +Worker4 +OutAir1
HALLWAY 5 +mazeShie +exit -Worker1 -L1
| +mazeShie +L1 -exit -L2
| +mazeShie +L2 -Worker2 -L1 -L3
| +mazeShie +L3 -L2 -enter
| +mazeShie +enter -Worker3 -L3
OUTAIR1 5 +air +OutAir1 -Worker4 -mazeShie
OUTAIR2 5 +air +OutAir2 -mazeShie
END
1.0 1.0 1.0 1.0 1.0 1.0 1.0
56000. 56000. 56000. 56000. 56000. 1.0 1.0
1.0
GEOEND
* Assign materials to the different regions
ASSIGNMA BLCKHOLE BLKBODY
ASSIGNMA VACUUM VOID
ASSIGNMA AIR AIR
ASSIGNMA Concrete WALLS
ASSIGNMA Concrete MAZESHIE
ASSIGNMA AIR BIASBOX
ASSIGNMA AIR ROOMAIR
ASSIGNMA AIR HALLWAY
ASSIGNMA AIR OUTAIR1
ASSIGNMA AIR OUTAIR2
ASSIGNMA WATER PHANTOM
ASSIGNMA WATER WORKER1
ASSIGNMA WATER WORKER2
ASSIGNMA WATER WORKER3
ASSIGNMA WATER WORKER4
* Concrete
* Concrete has a wide variation in density and composition. The above
* description is for poured structural concrete with 10% moisture
* content. Concrete block will have a density of about 2.05 g/cm3.
* Ranges of concrete composition are : C (8-25%), O (38-60%), Si (8-18%).
* Concrete composition can be analyzed cheaply by commercial laboratories.
MATERIAL 2.34 Concrete
COMPOUND 23.0 CARBON 40.0 OXYGEN 12.0 SILICONConcrete
COMPOUND 12.0 CALCIUM 10.0 HYDROGEN 2.0 MAGNESIUConcrete
BIASING 0.0 1. ROOMAIR ROOMAIR
BIASING 0.0 2. PHANTOM PHANTOM
BIASING 0.0 5. BIASBOX BIASBOX
89
BIASING 0.0 20. MAZESHIE MAZESHIE
BIASING 0.0 20. HALLWAY HALLWAY
BIASING 0.0 20. WORKER1 WORKER1
BIASING 0.0 20. WORKER2 WORKER2
BIASING 0.0 20. WORKER3 WORKER3
BIASING 0.0 40. OUTAIR1 OUTAIR1
BIASING 0.0 40. WORKER4 WORKER4
BIASING 0.0 40. OUTAIR2 OUTAIR2
EMFCUT 1.0E-5 BIASBOX BIASBOX
EMFCUT 1.0E-5 MAZESHIE MAZESHIE
EMFCUT 1.0E-5 HALLWAY HALLWAY
EMFCUT 1.0E-5 WORKER1 WORKER1
EMFCUT 1.0E-5 WORKER2 WORKER2
EMFCUT 1.0E-5 WORKER3 WORKER3
EMFCUT 1.0E-5 WORKER4 WORKER4
EMFCUT 1.0E-5 OUTAIR1 OUTAIR1
* Dose deposited in the maze
USRBIN 10. DOSE -21. -200.0 10. 1000.mazeDo20
USRBIN -690.0 -10.0 450.0 700. 8. 1100. &
* Energy deposited in the maze
USRBIN 10. ENERGY -22. -200.0 10. 1000.mazeEn20
USRBIN -690.0 -10.0 450.0 700. 8. 1100. &
* Proton Fluence in the maze (20cm slice)
USRBIN 10. PROTON -23. -200.0 10. 1000.mazePr20
USRBIN -690.0 -10.0 450.0 700. 8. 1100. &
* Helium Fluence in the maze (20cm slice)
USRBIN 10. 4-HELIUM -24. -200.0 10. 1000.mazeHe20
USRBIN -690.0 -10.0 450.0 700. 8. 1100. &
* Neutron Fluence in the maze (20cm slice)
USRBIN 10. NEUTRON -25. -200.0 10. 1000.mazeNe20
USRBIN -690.0 -10.0 450.0 700. 8. 1100. &
* Photon Fluence in the maze (20cm slice)
USRBIN 10. PHOTON -26. -200.0 10. 1000.mazePh20
USRBIN -690.0 -10.0 450.0 700. 8. 1100. &
* Heavy ion Fluence in the maze (20cm slice)
USRBIN 10. HEAVYION -27. -200.0 10. 1000.mazeHi20
USRBIN -690.0 -10.0 450.0 700. 8. 1100. &
* Neutrons entering the maze hallway
USRBDX 99. NEUTRON -40. BIASBOX HALLWAY 16000.NeutEnt
USRBDX 0.5 1E-14 300. 1. &
* Neutrons exiting the maze hallway
USRBDX 99. NEUTRON -41. HALLWAY OUTAIR1 16000.NeutExt
USRBDX 0.5 1E-14 200. 1. &
* photons entering the maze hallway
USRBDX 99. PHOTON -42. BIASBOX HALLWAY 16000.PhotEnt
USRBDX 0.5 1E-5 300. 1. &
* Photons exiting the maze hallway
USRBDX 99. PHOTON -43. HALLWAY OUTAIR1 16000.PhotExt
USRBDX 0.5 1E-5 200. 1. &
* Protons entering the maze hallway
USRBDX 99. PROTON -44. BIASBOX HALLWAY 16000.ProtEnt
USRBDX 0.5 1E-4 300. 1. &
* Protons exiting the maze hallway
USRBDX 99. PROTON -45. HALLWAY OUTAIR1 16000.ProtExt
USRBDX 0.5 1E-4 200. 1. &
* Helium entering the maze hallway
USRBDX 99. 4-HELIUM -46. BIASBOX HALLWAY 16000.He4Ent
USRBDX 0.5 1E-4 300. 1. &
90
* Helium exiting the maze hallway
USRBDX 99. 4-HELIUM -47. HALLWAY OUTAIR1 16000.He4Ext
USRBDX 0.5 1E-4 200. 1. &
* HeavyIons entering the maze hallway
USRBDX 99. HEAVYION -48. BIASBOX HALLWAY 16000.HiEnt
USRBDX 0.5 1E-4 300. 1. &
* HeavyIons exiting the maze hallway
USRBDX 99. HEAVYION -49. HALLWAY OUTAIR1 16000.HiExt
USRBDX 0.5 1E-4 200. 1. &
* Neutron spectrum in Worker 1
USRTRACK -1. NEUTRON -50. WORKER1 56000. 300.work1Ne
USRTRACK 0.5 1.0E-14 &
* Neutron spectrum in Worker 2
USRTRACK -1. NEUTRON -51. WORKER2 56000. 200.work2Ne
USRTRACK 0.5 1.0E-14 &
* Neutron spectrum in Worker 3
USRTRACK -1. NEUTRON -52. WORKER3 56000. 100.work3Ne
USRTRACK 0.5 1.0E-14 &
* Neutron spectrum in Worker 4
USRTRACK -1. NEUTRON -53. WORKER4 56000. 100.work4Ne
USRTRACK 0.5 1.0E-14 &
* Photon Spectrum in Worker 1
USRTRACK -1. PHOTON -54. WORKER1 56000. 300.work1Pho
USRTRACK 0.5 1.0E-5 &
* Photon Spectrum in Worker 2
USRTRACK -1. PHOTON -55. WORKER2 56000. 200.work2Pho
USRTRACK 0.5 1.0E-5 &
* Photon Spectrum in Worker 3
USRTRACK -1. PHOTON -56. WORKER3 56000. 100.work3Pho
USRTRACK 0.5 1.0E-5 &
* Photon spectrum in Worker 4
USRTRACK -1. PHOTON -57. WORKER4 56000. 100.work4Pho
USRTRACK 0.5 1.0E-5 &
* Proton Spectrum in Worker 1
USRTRACK -1. PROTON -58. WORKER1 56000. 300.work1Pr
USRTRACK 0.5 1.0E-4 &
* Proton Spectrum in Worker 2
USRTRACK -1. PROTON -59. WORKER2 56000. 200.work2Pr
USRTRACK 0.5 1.0E-4 &
* Proton Spectrum in Worker 3
USRTRACK -1. PROTON -60. WORKER3 56000. 100.work3Pr
USRTRACK 0.5 1.0E-4 &
* Proton spectrum in Worker 4
USRTRACK -1. PROTON -61. WORKER4 56000. 100.work4Pr
USRTRACK 0.5 1.0E-4 &
* Helium Spectrum in Worker 1
USRTRACK -1. 4-HELIUM -62. WORKER1 56000. 300.work1He4
USRTRACK 0.5 1.0E-4 &
* Helium Spectrum in Worker 2
USRTRACK -1. 4-HELIUM -63. WORKER2 56000. 200.work2He4
USRTRACK 0.5 1.0E-4 &
* Helium Spectrum in Worker 3
USRTRACK -1. 4-HELIUM -64. WORKER3 56000. 100.work3He4
USRTRACK 0.5 1.0E-4 &
* Helium spectrum in Worker 4
USRTRACK -1. 4-HELIUM -65. WORKER4 56000. 100.work4He4
USRTRACK 0.5 1.0E-4 &
* HeavyIon Spectrum in Worker 1
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USRTRACK -1. HEAVYION -66. WORKER1 56000. 300.work1Hi
USRTRACK 0.5 1.0E-4 &
* HeavyIon Spectrum in Worker 2
USRTRACK -1. HEAVYION -67. WORKER2 56000. 200.work2Hi
USRTRACK 0.5 1.0E-4 &
* HeavyIon Spectrum in Worker 3
USRTRACK -1. HEAVYION -68. WORKER3 56000. 100.work3Hi
USRTRACK 0.5 1.0E-4 &
* Proton spectrum in Worker 4
USRTRACK -1. HEAVYION -69. WORKER4 56000. 100.work4Hi
USRTRACK 0.5 1.0E-4 &
* Angular Yield of Neutrons exiting the Hallway (maze)
USRYIELD 124. NEUTRON -70. HALLWAY OUTAIR1 NeAngExt
USRYIELD 180. 0.0 180. 0.5 1.0E-14 3. &
* Angular Yield of Photons exiting the Hallway (maze)
USRYIELD 124. PHOTON -71. HALLWAY OUTAIR1 PhAngExt
USRYIELD 180. 0.0 180. 0.5 1.0E-5 3. &
* Equivalent Dose to Worker 1
USRBIN 12. DOSE-EQ -72. WORKER1 DoseEqW1
USRBIN WORKER1 1. 1. 1. &
* Equivalent Dose to Worker 2
USRBIN 12. DOSE-EQ -73. WORKER2 DoseEqW2
USRBIN WORKER2 1. 1. 1. &
* Equivalent Dose to Worker 3
USRBIN 12. DOSE-EQ -74. WORKER3 DoseEqW3
USRBIN WORKER3 1. 1. 1. &
* Equivalent Dose to Worker 4
USRBIN 12. DOSE-EQ -75. WORKER4 DoseEqW4
USRBIN WORKER4 1. 1. 1. &
* Total Dose to Worker 1
USRBIN 12. DOSE -76. WORKER1 DoseW1
USRBIN WORKER1 1. 1. 1. &
* Dose to Worker 1 from Neutrons
USRBIN 12. DOSE -77. WORKER1 NeutW1
USRBIN WORKER1 1. 1. 1. &
AUXSCORE USRBIN NEUTRON NeutW1 NeutW1
* Dose to Worker 1 from Photons
USRBIN 12. DOSE -78. WORKER1 PhotoW1
USRBIN WORKER1 1. 1. 1. &
AUXSCORE USRBIN PHOTON PhotoW1 PhotoW1
* Dose to Worker 1 from protons
USRBIN 12. DOSE -79. WORKER1 ProtoW1
USRBIN WORKER1 1. 1. 1. &
AUXSCORE USRBIN PROTON ProtoW1 ProtoW1
* Dose to Worker 1 from helium 4
USRBIN 12. DOSE -80. WORKER1 HeliumW1
USRBIN WORKER1 1. 1. 1. &
AUXSCORE USRBIN 4-HELIUM HeliumW1 HeliumW1
* Dose to Worker 1 from Heavy Ions
USRBIN 12. DOSE -81. WORKER1 HiW1
USRBIN WORKER1 1. 1. 1. &
AUXSCORE USRBIN HEAVYION HiW1 HiW1
* Total Dose to Worker 2
USRBIN 12. DOSE -82. WORKER2 DoseW2
USRBIN WORKER2 1. 1. 1. &
* Dose to Worker 2 from Neutrons
USRBIN 12. DOSE -83. WORKER2 NeutW2
USRBIN WORKER2 1. 1. 1. &
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AUXSCORE USRBIN NEUTRON NeutW2 NeutW2
* Dose to Worker 2 from Photons
USRBIN 12. DOSE -84. WORKER2 PhotoW2
USRBIN WORKER2 1. 1. 1. &
AUXSCORE USRBIN PHOTON PhotoW2 PhotoW2
* Dose to Worker 2 from protons
USRBIN 12. DOSE -85. WORKER2 ProtoW2
USRBIN WORKER2 1. 1. 1. &
AUXSCORE USRBIN PROTON ProtoW2 ProtoW2
* Dose to Worker 2 from helium 4
USRBIN 12. DOSE -86. WORKER2 HeliumW2
USRBIN WORKER2 1. 1. 1. &
AUXSCORE USRBIN 4-HELIUM HeliumW2 HeliumW2
* Dose to Worker 2 from Heavy Ions
USRBIN 12. DOSE -87. WORKER2 HiW2
USRBIN WORKER2 1. 1. 1. &
AUXSCORE USRBIN HEAVYION HiW2 HiW2
* Total Dose to Worker 3
USRBIN 12. DOSE -88. WORKER3 DoseW3
USRBIN WORKER3 1. 1. 1. &
* Dose to Worker 3 from Neutrons
USRBIN 12. DOSE -89. WORKER3 NeutW3
USRBIN WORKER3 1. 1. 1. &
AUXSCORE USRBIN NEUTRON NeutW3 NeutW3
* Dose to Worker 3 from Photons
USRBIN 12. DOSE -90. WORKER3 PhotoW3
USRBIN WORKER3 1. 1. 1. &
AUXSCORE USRBIN PHOTON PhotoW3 PhotoW3
* Dose to Worker 3 from protons
USRBIN 12. DOSE -91. WORKER3 ProtoW3
USRBIN WORKER3 1. 1. 1. &
AUXSCORE USRBIN PROTON ProtoW3 ProtoW3
* Dose to Worker 3 from helium 4
USRBIN 12. DOSE -92. WORKER3 HeliumW3
USRBIN WORKER3 1. 1. 1. &
AUXSCORE USRBIN 4-HELIUM HeliumW3 HeliumW3
* Dose to Worker 3 from Heavy Ions
USRBIN 12. DOSE -93. WORKER3 HiW3
USRBIN WORKER3 1. 1. 1. &
AUXSCORE USRBIN HEAVYION HiW3 HiW3
* Total Dose to Worker 4
USRBIN 12. DOSE -94. WORKER4 DoseW4
USRBIN WORKER4 1. 1. 1. &
* Dose to Worker 4 from Neutrons
USRBIN 12. DOSE -95. WORKER4 NeutW4
USRBIN WORKER4 1. 1. 1. &
AUXSCORE USRBIN NEUTRON NeutW4 NeutW4
* Dose to Worker 4 from Photons
USRBIN 12. DOSE -96. WORKER4 PhotoW4
USRBIN WORKER4 1. 1. 1. &
AUXSCORE USRBIN PHOTON PhotoW4 PhotoW4
* Dose to Worker 4 from protons
USRBIN 12. DOSE -97. WORKER4 ProtoW4
USRBIN WORKER4 1. 1. 1. &
AUXSCORE USRBIN PROTON ProtoW4 ProtoW4
* Dose to Worker 4 from helium 4
USRBIN 12. DOSE -98. WORKER4 HeliumW4
USRBIN WORKER4 1. 1. 1. &
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AUXSCORE USRBIN 4-HELIUM HeliumW4 HeliumW4
* Dose to Worker 4 from Heavy Ions
USRBIN 12. DOSE -99. WORKER4 HiW4
USRBIN WORKER4 1. 1. 1. &
AUXSCORE USRBIN HEAVYION HiW4 HiW4
* Set the random number seed
RANDOMIZ 1.
* Set the number of primary histories to be simulated in the run
START 1E6
STOP}
A.2 source.f User Routine
The fortran source.f file that defines the beam’s energy, weight and initial position.
* CREATE SOURCE.FOR
* COPY SOURCE
*
*=== source ===========================================================*
*
SUBROUTINE SOURCE ( NOMORE )
INCLUDE ’(DBLPRC)’
INCLUDE ’(DIMPAR)’
INCLUDE ’(IOUNIT)’
INCLUDE ’(BEAMCM)’
INCLUDE ’(CASLIM)’
INCLUDE ’(FHEAVY)’
INCLUDE ’(FLKSTK)’
INCLUDE ’(IOIOCM)’
INCLUDE ’(LTCLCM)’
INCLUDE ’(PAPROP)’
INCLUDE ’(SOURCM)’
INCLUDE ’(SUMCOU)’
*----------------------------------------------------------------------*
*
*
DIMENSION CUMPR(0:51), ENEDGE(52)
*these corresponds to 51 entries in both CUMPR and ENEDGE
*----------------------------------------------------------------------*
*
*
LOGICAL LFIRST
SAVE LFIRST
DATA LFIRST / .TRUE. /
*----------------------------------------------------------------------*
*Proton, Helium and Carbon must be seperated into individual source.f files.
*They are grouped together here in one file purely for ease of reading.
*Proton energy group *Helium energy group *Carbon energy group
DATA ENEDGE / DATA ENEDGE / DATA ENEDGE /
& 147.2945625711E-03, & 147.4149412804E-03, & 279.9634188908E-03,
& 147.8604514201E-03, & 147.9435498732E-03, & 281.021175846E-03,
& 148.4247559067E-03, & 148.4707725823E-03, & 282.0767793522E-03,
& 148.9874908402E-03, & 148.9966215298E-03, & 283.1302461547E-03,
& 149.5486707954E-03, & 149.5211086585E-03, & 284.1815927738E-03,
& 150.1083101186E-03, & 150.0442457355E-03, & 285.2308355086E-03,
& 150.6664229318E-03, & 150.5660443558E-03, & 286.2779904414E-03,
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& 151.2230231383E-03, & 151.0865159461E-03, & 287.3230734421E-03,
& 151.7781244271E-03, & 151.6056717678E-03, & 288.3661001718E-03,
& 152.3317402777E-03, & 152.1235229209E-03, & 289.4070860866E-03,
& 152.8838839644E-03, & 152.6400803466E-03, & 290.4460464419E-03,
& 153.434568561E-03, & 153.1553548311E-03, & 291.4829962957E-03,
& 153.9838069447E-03, & 153.6693570084E-03, & 292.5179505123E-03,
& 154.5316118004E-03, & 154.1820973631E-03, & 293.5509237657E-03,
& 155.0779956249E-03, & 154.693586234E-03, & 294.5819305436E-03,
& 155.6229707305E-03, & 155.2038338161E-03, & 295.6109851499E-03,
& 156.1665492491E-03, & 155.7128501642E-03, & 296.6381017088E-03,
& 156.7087431358E-03, & 156.220645195E-03, & 297.6632941676E-03,
& 157.2495641724E-03, & 156.7272286901E-03, & 298.6865762997E-03,
& 157.7890239711E-03, & 157.2326102985E-03, & 299.7079617081E-03,
& 158.327133978E-03, & 157.7367995393E-03, & 300.7274638282E-03,
& 158.8639054762E-03, & 158.2398058036E-03, & 301.7450959304E-03,
& 159.399349589E-03, & 158.7416383577E-03, & 302.7608711237E-03,
& 159.9334772836E-03, & 159.2423063447E-03, & 303.7748023576E-03,
& 160.4662993736E-03, & 159.7418187873E-03, & 304.7869024256E-03,
& 160.9978265222E-03, & 160.2401845899E-03, & 305.7971839675E-03,
& 161.5280692454E-03, & 160.7374125406E-03, & 306.8056594721E-03,
& 162.0570379143E-03, & 161.2335113136E-03, & 307.8123412797E-03,
& 162.5847427587E-03, & 161.728489471E-03, & 308.8172415846E-03,
& 163.1111938689E-03, & 162.2223554652E-03, & 309.8203724378E-03,
& 163.6364011991E-03, & 162.7151176404E-03, & 310.821745749E-03,
& 164.1603745696E-03, & 163.2067842349E-03, & 311.8213732891E-03,
& 164.6831236694E-03, & 163.6973633831E-03, & 312.8192666927E-03,
& 165.2046580588E-03, & 164.1868631167E-03, & 313.8154374601E-03,
& 165.7249871716E-03, & 164.6752913673E-03, & 314.8098969595E-03,
& 166.2441203175E-03, & 165.1626559678E-03, & 315.8026564294E-03,
& 166.7620666845E-03, & 165.6489646539E-03, & 316.7937269801E-03,
& 167.2788353413E-03, & 166.1342250662E-03, & 317.7831195968E-03,
& 167.7944352388E-03, & 166.6184447516E-03, & 318.7708451405E-03,
& 168.308875213E-03, & 167.101631165E-03, & 319.7569143506E-03,
& 168.8221639868E-03, & 167.583791671E-03, & 320.7413378469E-03,
& 169.3343101719E-03, & 168.064933545E-03, & 321.7241261311E-03,
& 169.8453222709E-03, & 168.5450639754E-03, & 322.705289589E-03,
& 170.3552086792E-03, & 169.0241900643E-03, & 323.6848384919E-03,
& 170.8639776872E-03, & 169.5023188296E-03, & 324.6627829991E-03,
& 171.3716374815E-03, & 169.9794572059E-03, & 325.6391331588E-03,
& 171.8781961475E-03, & 170.4556120465E-03, & 326.6138989105E-03,
& 172.3836616704E-03, & 170.930790124E-03, & 327.5870900864E-03,
& 172.8880419377E-03, & 171.4049981321E-03, & 328.5587164127E-03,
& 173.3913447402E-03, & 171.8782426869E-03, & 329.5287875119E-03,
& 173.893577774E-03, & 172.3505303281E-03, & 330.4973129039E-03,
& 174.3898258549E-03/ & 172.82186752E-03/ & 331.4643020078E-03/
~
* Cumulative spectrum (Beam Weights)
DATA CUMPR / 0.D0,
*...+....1....+....2....+....3....+....4....+....5....+....6....+....7..
& 0.0037617826,
& 0.0113572171,
& 0.0190511735,
& 0.026847045,
& 0.0347484179,
& 0.0427590866,
& 0.0508830711,
& 0.0591246358,
& 0.0674883104,
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& 0.0759789135,
& 0.0846015784,
& 0.0933617824,
& 0.1022653795,
& 0.1113186368,
& 0.1205282764,
& 0.1299015219,
& 0.1394461518,
& 0.14917056,
& 0.1590838253,
& 0.1691957909,
& 0.1795171563,
& 0.1900595838,
& 0.2008358222,
& 0.211859852,
& 0.2231470558,
& 0.2347144202,
& 0.246580777,
& 0.2587670911,
& 0.2712968098,
& 0.2841962879,
& 0.2974953106,
& 0.311227742,
& 0.3254323398,
& 0.3401537886,
& 0.3554440301,
& 0.3713639983,
& 0.3879859229,
& 0.4053964425,
& 0.4237009038,
& 0.4430294459,
& 0.4635458611,
& 0.4854609439,
& 0.5090534391,
& 0.5347046021,
& 0.5629589238,
& 0.5946399536,
& 0.6310973585,
& 0.6748275437,
& 0.7315147259,
& 0.822172059,
& 1/
*----------------------------------------------------------------------*
*...+....1....+....2....+....3....+....4....+....5....+....6....+....7..
*----------------------------------------------------------------------*
NOMORE = 0
* +-------------------------------------------------------------------*
* | First call initializations:
IF ( LFIRST ) THEN
* | *** The following 3 cards are mandatory ***
TKESUM = ZERZER
LFIRST = .FALSE.
LUSSRC = .TRUE.
* | *** User initialization ***
END IF
* |
* +-------------------------------------------------------------------*
* Sample the energy group
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XI = FLRNDM(DUMMY)
DO 500 K = 1, 52
IF(XI .LE. CUMPR(K)) THEN
*Carbon: NEUGRP = K
ENERGY = ENEDGE(K) -
& (XI-CUMPR(K-1))*(ENEDGE(K)-ENEDGE(K+1))/(CUMPR(K)-CUMPR(K-1))
GO TO 600
END IF
500 CONTINUE
STOP ’ Failed to sample the energy group’
600 CONTINUE
kount=kount+1
*
* Npflka is the stack counter: of course any time source is called it
* must be =0
NPFLKA = NPFLKA + 1
* Wt is the weight of the particle
WTFLK (NPFLKA) = ONEONE
WEIPRI = WEIPRI + WTFLK (NPFLKA)
* Particle type (1=proton.....). Ijbeam is the type set by the BEAM
* card
* +-------------------------------------------------------------------*
* | Heavy ion:
IF ( IJBEAM .EQ. -2 ) THEN
IJHION = IPROZ * 1000 + IPROA
IJHION = IJHION * 100 + KXHEAV
IONID = IJHION
CALL DCDION ( IONID )
CALL SETION ( IONID )
ILOFLK (NPFLKA) = IJHION
* |
* +-------------------------------------------------------------------*
* | Normal hadron:
ELSE
IONID = IJBEAM
ILOFLK (NPFLKA) = IJBEAM
END IF
* |
* +-------------------------------------------------------------------*
* From this point .....
* Particle generation (1 for primaries)
LOFLK (NPFLKA) = 1
* User dependent flag:
LOUSE (NPFLKA) = 0
* User dependent spare variables:
DO 100 ISPR = 1, MKBMX1
SPAREK (ISPR,NPFLKA) = ZERZER
100 CONTINUE
* User dependent spare flags:
DO 200 ISPR = 1, MKBMX2
ISPARK (ISPR,NPFLKA) = 0
200 CONTINUE
* Save the track number of the stack particle:
ISPARK (MKBMX2,NPFLKA) = NPFLKA
NPARMA = NPARMA + 1
NUMPAR (NPFLKA) = NPARMA
NEVENT (NPFLKA) = 0
DFNEAR (NPFLKA) = +ZERZER
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* ... to this point: don’t change anything
* Particle age (s)
AGESTK (NPFLKA) = +ZERZER
AKNSHR (NPFLKA) = -TWOTWO
* Group number for "low" energy neutrons
IGROUP (NPFLKA) = NEUGRP
* Kinetic energy of the particle (GeV)
*Proton:
TKEFLK (NPFLKA) = ENERGY
*Helium:
* TKEFLK (NPFLKA) = ENERGY*4.0D0
*Carbon:
* TKEFLK (NPFLKA) = ENERGY*12.0D0
* Particle momentum
PMOFLK (NPFLKA) = SQRT ( TKEFLK (NPFLKA) * ( TKEFLK (NPFLKA)
* + TWOTWO * AM (ILOFLK(NPFLKA)) ) )
* Cosines (tx,ty,tz)
TXFLK (NPFLKA) = UBEAM
TYFLK (NPFLKA) = VBEAM
TZFLK (NPFLKA) = WBEAM
* TZFLK (NPFLKA) = SQRT ( ONEONE - TXFLK (NPFLKA)**2
* & - TYFLK (NPFLKA)**2 )
* Polarization cosines:
TXPOL (NPFLKA) = -TWOTWO
TYPOL (NPFLKA) = +ZERZER
TZPOL (NPFLKA) = +ZERZER
* Particle coordinates [cm] that cover the volume in X and Y direction:
* Gaussian sigma 0.297(=0.7FWHM) to account for lateral spread of beam
*Proton:
CALL FLNRR2(RGAUS1, RGAUS2)
XFLK (NPFLKA) = (-3.43 + 0.297*RGAUS1)+ FLRNDM(DUMMY)*6.92
YFLK (NPFLKA) = (-3.445 + 0.297*RGAUS2)+ FLRNDM(DUMMY)*6.905
ZFLK (NPFLKA) = ZBEAM
*Helium:
* CALL FLNRR2(RGAUS1, RGAUS2)
* XFLK (NPFLKA) = (-3.15 + 0.297D0*RGAUS1)+ FLRNDM(DUMMY)*6.27
* YFLK (NPFLKA) = (-3.15 + 0.297D0*RGAUS2)+ FLRNDM(DUMMY)*6.34
* ZFLK (NPFLKA) = ZBEAM
*Carbon:
* CALL FLNRR2(RGAUS1, RGAUS2)
* XFLK (NPFLKA) = (-3.05 + 0.297*RGAUS1)+ FLRNDM(DUMMY)*6.1
* YFLK (NPFLKA) = (-3.05 + 0.297*RGAUS2)+ FLRNDM(DUMMY)*6.1
* ZFLK (NPFLKA) = ZBEAM
* Calculate the total kinetic energy of the primaries: don’t change
IF ( ILOFLK (NPFLKA) .EQ. -2 .OR. ILOFLK (NPFLKA) .GT. 100000 )
& THEN
TKESUM = TKESUM + TKEFLK (NPFLKA) * WTFLK (NPFLKA)
ELSE IF ( ILOFLK (NPFLKA) .NE. 0 ) THEN
TKESUM = TKESUM + ( TKEFLK (NPFLKA) + AMDISC (ILOFLK(NPFLKA)) )
& * WTFLK (NPFLKA)
ELSE
TKESUM = TKESUM + TKEFLK (NPFLKA) * WTFLK (NPFLKA)
END IF
* Flag this is prompt radiation
LRADDC (NPFLKA) = .FALSE.
RADDLY (NPFLKA) = ZERZER
* Here we ask for the region number of the hitting point.
* NREG (NPFLKA) = ...
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* The following line makes the starting region search much more
* robust if particles are starting very close to a boundary:
CALL GEOCRS ( TXFLK (NPFLKA), TYFLK (NPFLKA), TZFLK (NPFLKA) )
CALL GEOREG ( XFLK (NPFLKA), YFLK (NPFLKA), ZFLK (NPFLKA),
& NRGFLK(NPFLKA), IDISC )
* Do not change these cards:
CALL GEOHSM ( NHSPNT (NPFLKA), 1, -11, MLATTC )
NLATTC (NPFLKA) = MLATTC
CMPATH (NPFLKA) = ZERZER
CALL SOEVSV
RETURN
*=== End of subroutine Source =========================================*
END
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Appendix B
FLUKA Materials
Air
Note: Dry air (near sea level)
Density: 0.00120484g/cm3
Mass fraction:
0.0001248 Carbon
0.755267 Nitrogen
0.231781 Oxygen
0.012827 Argon
Water
Note: Water liquid H2O
Density: 1.00g/cm3
Molecular content:
2 Hydrogen
1 Oxygen
Concrete
Poured structural concrete with 10% moisture content.
Density: 2.34g/cm3
Molecular content:
23 Carbon
40 Oxygen
12 Silicon
12 Calcium
10 Hydrogen
2 Magnesium
Boron
Note: Pure Boron
Density: 2.37g/cm3
Atomic number: 5
100
Iron
Note: Pure Iron
Density: 7.874g/cm3
Atomic number: 26
Steel
Note: Stainless-Steel (typical)
Density: 8.0g/cm3
Molecular content:
18 Chromium
74 Iron
8 Nickel
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Appendix C
FLUKA Simulation Setups
All geometry dimensions and their relative placements are measured in cm and centred in
relation to the coordinate (0,0,0). Positive z-axis is the beam direction and is parallel to the floor,
ceiling and flank walls. Initial beam start location is (0,0,-100) and its direction is represented
by a red arrow in each of the respective two dimensional simulation layouts below. The main
patient phantom is made of water has and the dimension 70 × 20 × 40 and weighs a total of
54kg. It spans from -35cm to 35cm in x-direction, -10cm to 10cm in y-direction and 0cm to
40cm in z-direction. This is kept constant in all layouts where the patient phantom is present.
The Target Volume inside the patient phantom spans from -2.5cm to 2.5cm in both x- and y-
directions, and 15cm to 20cm in z-direction. Water equivalent phantoms dubbed Workers in
featured simulations have the same dimensions as the patient phantom but are rotated and
situated at the same height as the patient phantom and beam.
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Table C.1: Each Simulation setup is identified by a name and have been running a certain
number of primary particle to gain satisfactory statistics. Simulations marked with a ’*’ has
biasing applied to them and the percentage of treatment particles is therefore not applicable.
On average, all simulations ran for ≈ 90 hours.
Simulation Name Particle Tot. # of Primaries Percentage of # of simulation
Identification Type Simulated Treatment Fraction cycles
WaterPhantom Proton 300E6 0.52% 60
Helium 100E6 0.75% 20
Carbon 12E6 5.29% 12
ClosedRoom Proton 275E6 0.47% 55
Helium 64E6 0.48% 32
Carbon 12E6 5.29% 12
RightMaze* Proton 60E6 - 60
Helium 16E6 - 32
Carbon 2E6 - 10
RightMazeBoron* Proton 60E6 - 60
Helium 16E6 - 32
Carbon 2E6 - 10
MiddleMaze* Proton 50E6 - 50
Helium 25E6 - 25
Carbon 2.4E6 - 12
MiddleDoor* Proton 80E6 - 40
Helium 20E6 - 20
Carbon 2.8E6 - 14
PrimaryBarrier* Proton 36E6 - 36
Helium 15E6 - 15
Carbon 1.2E6 - 12
BeamDump* Proton 36E6 - 36
Helium 15E6 - 15
Carbon 1.2E6 - 12
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C.0.1 WaterPhantom
The "WaterPhantom" simulation is centred on a homogeneous water phantom functioning as
the patient as described above.
Figure C.1: Two dimensional layout drawing of the WaterPhantom setup in Geoviewer viewed
along the y-axis (top-down view).
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C.0.2 ClosedRoom
The "ClosedRoom" simulation introduces the treatment room walls that encompasses the pa-
tient phantom. The inside of the treatment room spans from -440cm to 440cm in x-direction,
-120cm to 330cm in y-direction and -800cm to 500cm in z-direction. Each flank wall, back wall,
floor and ceiling is 200cm thick and made of concrete. The primary front wall functioning as
the primary barrier is 400cm thick and spans from -640cm to 640cm in x-direction, -320cm to
530cm in y-direction and 500cm to 900cm in z-direction. The red arrow illustrates the beam
and its direction.
(a) Layout drawing of the treatment room setup in Geoviewer viewed along the y-axis (top-down view).
(b) Layout drawing of the treatment room setup in Geoviewer viewed along the x-axis (side view).
Figure C.2: The "ClosedRoom" setup in Geoviewer viewed from the top-down (a) and from the
side (b).
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C.0.3 RightMaze
The "RightMaze" simulation introduces the maze located inside the primary barrier as seen
in the two-dimensional layout drawing, figure C.3. Each of the three maze arms are 80cm
thick and the maze hallway cross section has the dimensions 80cm× 200cm (door sized) in x
and y respectively. Four water equivalent phantoms are placed inside and outside the maze
and dubbed Worker1, Worker2, Worker3 and Worker4. They are made of water and have the
same dimensions as the patient phantom, only rotated. The walls and maze arms are made of
concrete.
Figure C.3: Two dimensional layout of the RightMaze setup in Geoviewer and viewed along
the Y-axis (top-down view).
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C.0.4 RightMazeBoron
"RightMazeBoron" contains two 10cm thick boron layers (BoronLayer1 and BoronLayer2) that
covers the first 10cm of the two inner maze arms. Otherwise the maze is identical to the maze
found in "RightMaze".
Figure C.4: Two dimensional layout of the RightMazeBoron setup in Geoviewer and viewed
along the Y-axis (top-down view).
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C.0.5 MiddleMaze
An identical maze as the one found in "RightMaze" and "RihtMazeBoron"is placed inside the
right flank wall of the treatment room. The maze is made of concrete and four worker phan-
toms are placed at the positions shown in figure C.5.
Figure C.5: Two dimensional layout of the "MiddleMaze" setup in Geoviewer and viewed along
the Y-axis (top-down view).
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C.0.6 MiddleDoor
In this simulation the maze ("MiddleMaze") is exchanged with a straight corridor and a 100cm
thick iron door in the middle of it. Two water phantoms, Worker3 placed directly outside the
corridor, and Worker4 placed 150cm to the left of Worker3 and thus placing it behind the wall
as illustrated in the layout drawing in figure ??.
(a) Layout drawing of the middle door setup in Geoviewer viewed along the y-axis (top-down view).
(b) Layout drawing of the middle door setup in Geoviewer viewed along the x-axis (side view).
Figure C.6: The "MiddleDoor" setup in Geoviewer viewed from the top-down (a) and from the
side (b).
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C.0.7 PrimaryBarrier
The primary barrier (front wall) is 400cm thick and divided into four regions equally spaced
(100cm) for scoring purposes. A water equivalent phantom, Worker4 is placed on the other
side of the primary wall at the same height as the patient phantom.
Figure C.7: Two dimensional layout of the "PrimaryBarrier" setup in Geoviewer and viewed
along the Y-axis (top-down view).
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C.0.8 BeamDump
This simulation differentiates itself from "PrimaryBarrier" by removing the patient phantom
and adding a 30cm thick steel layer (SteelLayer) to the primary barrier.
Figure C.8: Two dimensional layout of the "BeamDump" setup in Geoviewer and viewed along
the Y-axis (top-down view).
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Appendix D
Differential Fluence of Secondary Particles Exit-
ing Treatment Phantom
(a) Secondary Protons exiting the treatment
phantom.
(b) Secondary helium 4 exiting the treatment
phantom.
(c) Secondary particles heavier than helium 4
(A<4) exiting the treatment phantom.
Figure D.1: Differential fluence spectrum of some secondary fragmentation particles exiting
the treatment phantom.
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Appendix E
Treatment Phantom Dose and Fluence (Wall Com-
parison)
The difference between the absorbed dose and fluence in the treatment phantom with and
without the treatment room walls, is obtained by subtracting the dose "Without Walls" from
the dose "With Walls", which is expected to be higher due to backscattering. The measurements
and results are listed in table E.1 below. Instances where there is no difference, or when the
difference is smaller then the error, are marked with "-".
Table E.1: Total absorbed dose in the treatment phantom per treatment fraction
[Gy/treatment f raction].
Simulated Dose Without Walls Dose With Walls Difference in Relative
Particle [Gy/treatment] [Gy/treatment] absorbed dose change [%]
Proton 2.651E-2±1.788E-7 2.651E-2±2.326E-7 - -
Helium 2.341E-2±3.768E-7 2.341E-2±5.068E-7 - -
Carbon 2.562E-2±1.730E-6 2.561E-2±1.295E-6 -3.58E-6±1.51E-6 -0.01±0.006
The difference between the fluence in the treatment phantom is obtained by subtracting the
fluence "Without Walls" from the fluence "With Walls", which is expected to be higher due
to backscattering, and expressing it as a relative change [%]. The measurements and results
are listed in table E.2 below. Instances where there is no difference or where the difference is
smaller then the error, are marked with "-".
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Table E.2: The fluence of selected secondary particles inside the treatment phantom normalised
to treatment fraction [n/cm2/Treatment f raction].
Simulated Particle fluence Change in
Particle [n/cm2/treatment] Without Walls With Walls fluence [%]
Proton
Secondary Protons 6.00E5±5.91E0 6.00E5±7.71E0 -
Neutrons 4.20E6±9.36E2 4.21E6±1.05E3 0.29±0.02
Photons 3.27E6±7.68E2 3.28E6±6.39E2 0.5±0.02
He4 8.64E2±2.96E-1 8.64E2±2.75E-1 -
Heavy Ions 2.86E1±1.94E-2 2.86E1±2.74E-2 -
Helium
Protons 6.97E5±2.04E2 6.97E5±2.58E2 -
Neutrons 6.37E6±1.55E3 6.39E6±1.77E3 0.27±0.03
Photons 2.59E6±6.10E2 2.61E6±7.93E2 0.82±0.03
Secondary He4 2.38E4±9.08E-1 2.38E4±1.33E0 0.06±0.005
Heavy Ions 3.48E2±3.84E-1 3.49E2±6.77E-1 -
Carbon
Protons 1.61E6±1.74E2 1.61E6±4.89E2 0.07±0.02
Neutrons 5.41E6±1.67E3 5.42E6±2.83E3 0.3±0.04
Photons 3.05E6±1.11E3 3.07E6±8.59E2 0.7±0.03
He4 4.16E5±1.45E2 4.16E5±2.4E2 -
Heavy Ions(-Carbon) 1.27E5±1.75E1 1.27E5±1.44E1 -
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Appendix F
Effective Dose Measurements in Worker Phantoms
Table F.1: Collection of the effective dose to "Workers" per treatment fraction [mSv/tr. f rac.] from each treatment beam simulated in each
individual simulation setup.
Simulation Setup Particle Type Effective Dose to Effective Dose to Effective Dose to Effective Dose to
Worker1 [mSv/tr.frac.] Worker2 [mSv/tr.frac.] Worker3 [mSv/tr.frac.] Worker4 [mSv/tr.frac.]
Proton 1.04E-3±1.06E-5 1.02E-4±1.29E-6 4.07E-6±1.99E-7 8.26E-7±8.45E-8
RightMaze Helium 1.70E-3±1.28E-5 1.86E-4±1.74E-6 9.20E-6±2.41E-7 2.59E-6±1.65E-7
Carbon 2.86E-3±1.34E-5 4.11E-4±3.02E-6 3.16E-5±5.76E-7 1.19E-5±5.99E-7
Proton 1.04E-3±1.09E-5 9.84E-5±1.27E-6 3.94E-6±2.31E-7 1.03E-6±1.04E-7
RightMazeBoron Helium 1.69E-3±9.01E-6 1.81E-4±1.71E-6 9.24E-6±3.87E-7 2.39E-6±1.44E-7
Carbon 2.86E-3±1.34E-5 4.11E-4±3.02E-6 3.16E-5±5.76E-7 1.19E-5±5.99E-7
Proton 2.83E-4±4.56E-6 4.78E-6±1.79E-7 2.31E-6±3.70E-8 4.02E-8±1.81E-8
MiddleMaze Helium 4.20E-4±3.98E-6 7.76E-6±1.26E-7 3.78E-6±1.49E-7 1.01E-7±2.08E-8
Carbon 4.59E-4±7.22E-6 1.04E-5±2.97E-7 6.22E-6±1.24E-6 1.91E-7±3.14E-8
Proton 1.29E-7±1.34E-8 5.92E-9±3.00E-9
MiddleDoor Helium - - 1.91E-7±1.86E-8 3.43E-8±1.77E-8
Carbon 5.67E-7±2.51E-7 9.31E-8±2.93E-8
Proton 5.08E-8±3.93E-8
PrimaryBarrier Helium - - - 1.39E-6±7.10E-8
Carbon 1.07E-5±4.61E-7
Proton 1.06E-7±3.11E-8
BeamDump Helium - - - 1.15E-6±1.41E-7
Carbon 8.14E-6±2.66E-7
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